<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Splinting for carpal tunnel syndrome - Karjalainen, TV - 2023 | Cochrane Library</title> <meta content="Splinting for carpal tunnel syndrome - Karjalainen, TV - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010003.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Splinting for carpal tunnel syndrome - Karjalainen, TV - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010003.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010003.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Splinting for carpal tunnel syndrome" name="citation_title"/> <meta content="Teemu V Karjalainen" name="citation_author"/> <meta content="teemukarjalainen@me.com" name="citation_author_email"/> <meta content="Vieda Lusa" name="citation_author"/> <meta content="Hospital Nova of Central Finland, Central Finland Healthcare District" name="citation_author_institution"/> <meta content="Matthew J Page" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Denise O'Connor" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Nicola Massy-Westropp" name="citation_author"/> <meta content="University of South Australia" name="citation_author_institution"/> <meta content="Susan E Peters" name="citation_author"/> <meta content="Harvard TH Chan School of Public Health" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD010003.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/02/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010003.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010003.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010003.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Carpal Tunnel Syndrome [therapy]; Hand; *Occupational Therapy; Quality of Life; Upper Extremity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010003.pub2&amp;doi=10.1002/14651858.CD010003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="Oy81c7tH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010003\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010003\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ko","ms","hr","fr","hu","zh_HANS","zh_HANT","th","ja","fa","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010003.pub2",title:"Splinting for carpal tunnel syndrome",firstPublishedDate:"Feb 27, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neuromuscular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010003.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010003.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010003.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010003.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010003.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010003.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010003.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010003.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010003.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010003.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9227 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010003.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-sec-0189"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-sec-0179"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/appendices#CD010003-sec-0194"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/supinfo/CD010003StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/supinfo/CD010003StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Splinting for carpal tunnel syndrome</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#CD010003-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Teemu V Karjalainen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#CD010003-cr-0005">Vieda Lusa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#CD010003-cr-0006">Matthew J Page</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#CD010003-cr-0007">Denise O'Connor</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#CD010003-cr-0008">Nicola Massy-Westropp</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information#CD010003-cr-0009">Susan E Peters</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information/en#CD010003-sec-0206">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 February 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010003.pub2">https://doi.org/10.1002/14651858.CD010003.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010003-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010003-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010003-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010003-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010003-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010003-abs-0004">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD010003-abs-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010003-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010003-abs-0001" lang="en"> <section id="CD010003-sec-0001"> <h3 class="title" id="CD010003-sec-0001">Background</h3> <p>Carpal tunnel syndrome (CTS) is a compression neuropathy of the median nerve causing pain and numbness and tingling typically in the thumb, index and middle finger. It sometimes results in muscle wasting, diminished sensitivity and loss of dexterity. Splinting the wrist (with or without the hand) using an orthosis is usually offered to people with mild‐to‐moderate findings, but its effectiveness remains unclear. </p> </section> <section id="CD010003-sec-0002"> <h3 class="title" id="CD010003-sec-0002">Objectives</h3> <p>To assess the effects (benefits and harms) of splinting for people with CTS.</p> </section> <section id="CD010003-sec-0003"> <h3 class="title" id="CD010003-sec-0003">Search methods</h3> <p>On 12 December 2021, we searched the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE, Embase, AMED, CINAHL, ClinicalTrials.gov, and WHO ICTRP with no limitations. We checked the reference lists of included studies and relevant systematic reviews for studies. </p> </section> <section id="CD010003-sec-0004"> <h3 class="title" id="CD010003-sec-0004">Selection criteria</h3> <p>Randomised trials were included if the effect of splinting could be isolated from other treatment modalities. The comparisons included splinting versus no active treatment (or placebo), splinting versus another disease‐modifying non‐surgical treatment, and comparisons of different splint‐wearing regimens. We excluded studies comparing splinting with surgery or one splint design with another. We excluded participants if they had previously undergone surgical release. </p> </section> <section id="CD010003-sec-0005"> <h3 class="title" id="CD010003-sec-0005">Data collection and analysis</h3> <p>Review authors independently selected trials for inclusion, extracted data, assessed study risk of bias and the certainty in the body of evidence for primary outcomes using the GRADE approach, according to standard Cochrane methodology. </p> </section> <section id="CD010003-sec-0006"> <h3 class="title" id="CD010003-sec-0006">Main results</h3> <p>We included 29 trials randomising 1937 adults with CTS. The trials ranged from 21 to 234 participants, with mean ages between 42 and 60 years. The mean duration of CTS symptoms was seven weeks to five years. Eight studies with 523 hands compared splinting with no active intervention (no treatment, sham‐kinesiology tape or sham‐laser); 20 studies compared splinting (or splinting delivered along with another non‐surgical intervention) with another non‐surgical intervention; and three studies compared different splinting regimens (e.g. night‐time only versus full time). </p> <p>Trials were generally at high risk of bias for one or more domains, including lack of blinding (all included studies) and lack of information about randomisation or allocation concealment in 23 studies. </p> <p>For the primary comparison, splinting compared to no active treatment, splinting may provide little or no benefits in symptoms in the short term (&lt; 3 months). The mean Boston Carpal Tunnel Questionnaire (BCTQ) Symptom Severity Scale (SSS) (scale 1 to 5, higher is worse; minimal clinically important difference (MCID) 1 point) was 0.37 points better with splint (95% confidence interval (CI) 0.82 better to 0.08 worse; 6 studies, 306 participants; low‐certainty evidence) compared with no active treatment. Removing studies with high or unclear risk of bias due to lack of randomisation or allocation concealment supported our conclusion of no important effect (mean difference (MD) 0.01 points worse with splint; 95% CI 0.20 better to 0.22 worse; 3 studies, 124 participants). In the long term (&gt; 3 months), we are uncertain about the effect of splinting on symptoms (mean BCTQ SSS 0.64 better with splinting; 95% CI 1.2 better to 0.08 better; 2 studies, 144 participants; very low‐certainty evidence). </p> <p>Splinting probably does not improve hand function in the short term and may not improve hand function in the long term. In the short term, the mean BCTQ Functional Status Scale (FSS) (1 to 5, higher is worse; MCID 0.7 points) was 0.24 points better (95% CI 0.44 better to 0.03 better; 6 studies, 306 participants; moderate‐certainty evidence) with splinting compared with no active treatment. In the long term, the mean BCTQ FSS was 0.25 points better (95% CI 0.68 better to 0.18 worse; 1 study, 34 participants; low‐certainty evidence) with splinting compared with no active treatment. </p> <p>Night‐time splinting may result in a higher rate of overall improvement in the short term (risk ratio (RR) 3.86, 95% CI 2.29 to 6.51; 1 study, 80 participants; number needed to treat for an additional beneficial outcome (NNTB) 2, 95% CI 2 to 2; low‐certainty evidence).  </p> <p>We are uncertain if splinting decreases referral to surgery, RR 0.47 (95% CI 0.14 to 1.58; 3 studies, 243 participants; very low‐certainty evidence).  </p> <p>None of the trials reported health‐related quality of life.</p> <p>Low‐certainty evidence from one study suggests that splinting may have a higher rate of adverse events, which were transient, but the 95% CIs included no effect. Seven of 40 participants (18%) reported adverse effects in the splinting group and 0 of 40 participants (0%) in the no active treatment group (RR 15.0, 95% CI 0.89 to 254.13; 1 study, 80 participants).  </p> <p>There was low‐ to moderate‐certainty evidence for the other comparisons: splinting may not provide additional benefits in symptoms or hand function when given together with corticosteroid injection (moderate‐certainty evidence) or with rehabilitation (low‐certainty evidence); nor when compared with corticosteroid (injection or oral; low certainty), exercises (low certainty), kinesiology taping (low certainty), rigid taping (low certainty), platelet‐rich plasma (moderate certainty), or extracorporeal shock wave treatment (moderate certainty). Splinting for 12 weeks may not be better than six weeks, but six months of splinting may be better than six weeks of splinting in improving symptoms and function (low‐certainty evidence). </p> </section> <section id="CD010003-sec-0007"> <h3 class="title" id="CD010003-sec-0007">Authors' conclusions</h3> <p>There is insufficient evidence to conclude whether splinting benefits people with CTS. Limited evidence does not exclude small improvements in CTS symptoms and hand function, but they may not be clinically important, and the clinical relevance of small differences with splinting is unclear. Low‐certainty evidence suggests that people may have a greater chance of experiencing overall improvement with night‐time splints than no treatment. As splinting is a relatively inexpensive intervention with no plausible long‐term harms, small effects could justify its use, particularly when patients are not interested in having surgery or injections. </p> <p>It is unclear if a splint is optimally worn full time or at night‐time only and whether long‐term use is better than short‐term use, but low‐certainty evidence suggests that the benefits may manifest in the long term. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010003-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010003-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010003-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010003-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010003-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010003-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010003-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/hu#CD010003-abs-0010">Magyar</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010003-abs-0018">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010003-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010003-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010003-abs-0021">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD010003-abs-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010003-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010003-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010003-abs-0002" lang="en"> <h3>Splinting for carpal tunnel syndrome</h3> <p><b>Review question</b> </p> <p>This Cochrane review aimed to compare the benefits and harms of wrist splints with no treatment or other types of treatment for people with carpal tunnel syndrome (CTS). </p> <p><b>Background</b> </p> <p>CTS is a condition where one of the two main nerves in the wrist is compressed. This can lead to pain in the hand and wrist as well as numbness and tingling in the thumb, index and middle finger. Severe compression may result in wasting of hand muscles and loss of dexterity of the hand. CTS is more common in women and in people over 50 years of age.  </p> <p>Many people undergo surgery to treat CTS, though usually non‐surgical treatments, such as splinting, corticosteroid injections (a drug that reduces inflammation) or exercises are offered first. Splinting involves immobilisation of the wrist in a neutral (straight) position, usually leaving the fingers and thumb free to move. </p> <p><b>Study characteristics</b> </p> <p>We collected and analysed all relevant studies to answer our review question and found 29 studies that assessed the safety and benefit of splinting for people with CTS. The average ages of participants were between 42 and 60 years, the number of participants was 1937, and 81% were women. Most had mild‐to‐moderate symptoms. </p> <p><b>Key results</b> </p> <p>When worn for fewer than three months, splinting may not improve CTS symptoms and probably does not improve hand function compared with no intervention. However, people who used a night‐time splint tended to report that overall they felt improvement compared with those that did not use a splint. </p> <p>In the longer term (more than 3 months), we are still uncertain of the benefits of splinting due to few studies and inconsistent findings across similar studies. We cannot say for certain if splinting provides meaningful improvements in symptoms or function.   </p> <p>We are also uncertain if splinting reduces the need for surgery because only three studies reported this outcome. Splinting may cause temporary side effects such as difficulty in falling asleep or transient tingling after removal of the splint; none of the trials reported any serious side effects. None of the studies reported whether splints improved quality of life. </p> <p>Some studies assessed if splinting improves outcomes when delivered alongside other treatments. The results suggested that splinting may make little or no difference to outcomes when given together with corticosteroid injection or with various types of rehabilitation.  </p> <p>Splinting was compared with other types of treatments. Splinting does not appear to improve outcomes compared with corticosteroid (injection or oral), exercises, kinesiology taping (stretchy tape), rigid taping, and probably does not improve outcomes compared with platelet‐rich plasma (concentrate of plasma and platelet derived from blood) or extracorporeal shock wave treatment (pulses of high energy sound).  </p> <p>Some studies compared different splint‐wearing regimens. One study found that six months of splinting may improve symptoms and function compared with six weeks of splinting. Another study found that full‐time splinting may not improve outcomes compared to night‐time splinting. </p> <p><b>Author's conclusions</b> </p> <p>Currently, there is limited evidence supporting the use of wrist splints to treat CTS as there are few studies and their findings are inconsistent. While it appears that splinting may not make symptoms worse or result in side effects, splinting may provide little or no benefit for CTS symptoms and hand function, especially in the short term (less than 3 months). One study suggests that night‐time splinting may increase the chance of overall improvement compared with no treatment. Benefits of splinting may occur after months of use, but we need well‐designed research studies to establish how effective splinting is, and to identify the best way to use splints (night‐time or full‐time use; long‐term or short‐term use).  </p> <p>Splinting is relatively inexpensive and has no known long‐term side effects. Therefore, even small benefits may justify its use in people who are not interested in invasive interventions such as surgery.  </p> <p><b>Certainty of evidence</b> </p> <p>People in the studies were aware of their treatment. This knowledge can produce more favourable assessments of benefit than when people are unaware of treatment ('blinded'). In the few studies that examined the same treatments and outcomes, findings were inconsistent.  </p> <p>The evidence is up‐to‐date to December 2021.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010003-sec-0189" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010003-sec-0189"></div> <h3 class="title" id="CD010003-sec-0190">Implications for practice</h3> <section id="CD010003-sec-0190"> <p>There is insufficient evidence to conclude whether wrist splinting provides clinically meaningful benefit for people with carpal tunnel syndrome (CTS). Current limited evidence does not exclude small improvements in CTS symptoms and hand function, but they may not be clinically important. However, the clinical relevance of small differences is still unclear and further research may change this conclusion. People may have greater chance of experiencing overall improvement when they use night‐time splints compared with no splints.  </p> <p>Since splinting is a relatively inexpensive intervention with no plausible long‐term harms, small effects (smaller than the MCID value) could justify use, particularly when people have mild‐to‐moderate CTS symptoms and are not interested in having surgery or injections. </p> <p>It is still unclear if splint should be used full‐time or at night‐time only and whether long‐term use is better than short‐term use for best response. However, low‐certainty evidence suggests that the benefits may manifest at long‐term follow‐up (after three months) and therefore longer treatment periods can be tried if the person with CTS does not develop adverse effects or worsening of symptoms. </p> </section> <h3 class="title" id="CD010003-sec-0191">Implications for research</h3> <section id="CD010003-sec-0191"> <p>As long as the efficacy of splinting is unclear, comparing splinting with other treatment modalities (often of ambiguous efficacy) may not improve our understanding of the role of splinting in the treatment of CTS. There is an apparent need for a large rigorous trial comparing splinting with no splinting or placebo and only one of the identified ongoing trials will address this research question (<a href="./references#CD010003-bbs2-0108" title="AtroshiI , TadjerbashiK , McCabeSJ , RanstamJ . Treatment of carpal tunnel syndrome with wrist splinting: study protocol for a randomized placebo-controlled trial. Trials2019;20(1):531. [DOI: https://doi.org/10.1186/s13063-019-3635-6]ISRCTN81836603. Evaluation of wrist splinting for the treatment of carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN81836603 (first received 2 May 2018). ">Atroshi 2019</a>). Besides measuring improvement in symptoms and function, the trial authors should measure overall/global improvement, generic health‐related quality of life, and record adverse effects and referral to surgery. </p> <p>The trials should preferably have a long follow‐up (and continue the intervention for 6 to 12 months or longer) to assess if any effects endure or manifest late. It may also be wise to further explore the optimal splinting strategy in terms of full‐time versus night‐time‐only splinting – people with predominantly night‐time symptoms may be a subgroup worth assessing separately, measuring specifically night‐time symptom relief. Baseline symptom severity is a potential effect modifier and future studies could try to assess if there are subgroups of people that benefit more from splinting.  </p> <p>If participants with bilateral CTS are included in trials, trialists should use statistical methods which take the dependency between wrists into account, and report which statistical methods they used to achieve this. Lastly, MCID values in people undergoing splinting warrants further assessment, as this value can greatly impact the interpretation of the evidence. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010003-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010003-sec-0008"></div> <div class="table" id="CD010003-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b> SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> carpal tunnel syndrome<br/><b>Setting: </b> outpatient clinics in Italy, Thailand and Turkey; hospital clinic in Australia; education and research hospital in Turkey; auto assembly plant in the USA<br/><b>Intervention:</b> SPLINT<br/><b>Comparison:</b> NO ACTIVE TREATMENT </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NO ACTIVE TREATMENT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with SPLINT</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CTS symptoms (Boston CTS questionnaire) ‐ short‐term improvement: &lt; 3 months<br/>Scale: 1 to 5, higher is worse </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean CTS symptoms severity was <b>2.37 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.37 points better</b><br/>(0.82 better to 0.08 worse) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Splint may not improve CTS symptoms in the short term. Absolute difference 9.25% better (20.5% better to 2% worse) with splint<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CTS symptoms (Boston CTS questionnaire) ‐ long‐term improvement: &gt; 3 months<br/>Scale: 1 to 5, higher is worse </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean CTS symptoms severity was <b>2.48 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.64 points better</b><br/>(1.2 better to 0.08 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain if splint improves CTS symptoms in the long term. Absolute difference 16% better (30% better to 2% better) with splint </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Function (Boston CTS questionnaire) ‐ long‐term improvement: &gt; 3 months<br/>Scale: 1 to 5, higher is worse </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean function was <b>1.77 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.25 points better</b><br/>(0.68 better to 0.18 worse) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Splint may not improve hand function in the long term. Absolute difference 6.25% better (17% better to 4.5% worse) with splint </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Overall improvement (improved/not improved or worsened) ‐ short‐term improvement: &lt; 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.86<br/>(2.29 to 6.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>More people may report overall improvement in the short term with a splint than without a splint. Absolute risk difference 75% better (61% better to 89% better ) with splint. NNTB 2 (95% CI 2 to 2) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>965 per 1000</b><br/>(573 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life ‐ long‐term improvement: &gt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable. We are uncertain about the effect.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effects</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 15.00<br/>(0.89 to 254.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Splint may increase risk of transient adverse effects. Absolute risk difference 17% worse (5% worse to 30% worse) with splint </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not calculable from the study data. 0/40 (0%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not calculable from the study data. 7/40 (18%)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Referral for surgery</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.47<br/>(0.14 to 1.58) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>243<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain if splint can reduce referral for surgery. Absolute risk difference 4% better (11% better  to 3% worse) with splint </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b><br/>(11 to 125) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio; <b>CTS</b>: carpal tunnel syndrome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for high risk of bias in the included studies (lack of blinding)<br/><sup>b</sup>Downgraded one level for inconsistency (the estimates were not consistent between the studies)<br/><sup>c</sup>Absolute risk difference calculated as risk in control group ‐ risk in the splinting group<br/><sup>d</sup>Downgraded for imprecision (the 95% did not exclude clinically relevant effects)<br/><sup>e</sup>Downgraded twice for very serious imprecision (95% CIs included substantial effect in both directions)<br/>  </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010003-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010003-sec-0009"></div> <section id="CD010003-sec-0010"> <h3 class="title" id="CD010003-sec-0010">Description of the condition</h3> <p>Carpal tunnel syndrome (CTS) refers to a condition where the median nerve function is compromised because of compression in the carpal tunnel. Symptoms of CTS include pain in the wrist and hand which can spread to the arm and paraesthesiae (numbness or tingling) in the thumb, index, middle and radial half of the ring finger (<a href="./references#CD010003-bbs2-0116" title="AtroshiI , GummessonC , JohnssonR , OrnsteinE , RanstamJ , RosénI . Prevalence of carpal tunnel syndrome in a general population. JAMA1999;282(2):153-8. [PMID: 10411196]">Atroshi 1999</a>). Advanced CTS can result in loss of sensitivity in the thumb, index and middle finger, thenar muscle weakness and atrophy and subsequent loss of dexterity (<a href="./references#CD010003-bbs2-0140" title="KeirP , RempelD . Pathomechanics of peripheral nerve loading. Journal of Hand Therapy2005;18(2):259-69. [PMID: 15891983]">Keir 2005</a>). Suspected risk factors for CTS include diabetes, obesity, menopause, arthritis, hypothyroidism, smoking, and pregnancy (<a href="./references#CD010003-bbs2-0153" title="PaduaL , CoraciD , ErraC , PazzagliaC , PaolassoI , LoretiC , et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurology2016;15(12):1273-84. [DOI: 10.1016/S1474-4422(16)30231-9] [PMID: 27751557]">Padua 2016</a>). </p> <p>The course of CTS is not predictable: some people progress from intermittent paraesthesia to more constant paraesthesia, and eventual thenar atrophy, others experience intermittent exacerbation of sensory symptoms over many years, while others experience spontaneous (and lasting) remission (<a href="./references#CD010003-bbs2-0117" title="BraunRM , DavidsonK , DoehrS . Provocative testing in the diagnosis of dynamic carpal tunnel syndrome. Journal of Hand Surgery (American Volume)1989;14(2 Pt 1):195-7. [PMID: 2703665]">Braun 1989</a>). There is no reliable data on the number of people who experience spontaneous remission, as such information is often based on assessment using nerve conduction studies, which have been found to correlate weakly with clinical outcomes (<a href="./references#CD010003-bbs2-0133" title="HardoimDG , De OliveiraGB , KouyoumdjianJA . Carpal tunnel syndrome: long-term nerve conduction studies in 261 hands. Arquivos de Neuro-Psiquiatria2009;67(1):69-73.">Hardoim 2009</a>; <a href="./references#CD010003-bbs2-0152" title="PaduaL , PaduaR , Lo MonacoM , AprileI , TonaliP . Multiperspective assessment of carpal tunnel syndrome: a multicenter study. Italian CTS Study Group. Neurology1999;53(8):1654-9.">Padua 1999</a>; <a href="./references#CD010003-bbs2-0161" title="ResendeLA , TaharaA , FonsecaRG , SardenbergT . The natural history of carpal tunnel syndrome: a study of 20 hands evaluated 4 to 9 years after initial diagnosis. Electromyography and Clinical Neurophysiology2003;43(5):301-4.">Resende 2003</a>). </p> <p>The reported prevalence and incidence of CTS has varied across studies depending on the diagnostic criteria used. Results of a Swedish study suggest that the prevalence of CTS in the general population is 3.8% for clinically diagnosed cases and 2.7% for electrophysiologically confirmed cases (<a href="./references#CD010003-bbs2-0116" title="AtroshiI , GummessonC , JohnssonR , OrnsteinE , RanstamJ , RosénI . Prevalence of carpal tunnel syndrome in a general population. JAMA1999;282(2):153-8. [PMID: 10411196]">Atroshi 1999</a>), and as high as 7.8% in the U.S. working population (<a href="./references#CD010003-bbs2-0121" title="DaleAM , Harris-AdamsonC , RempelD , GerrF , HegmannK , SilversteinB , et al. Prevalence and incidence of carpal tunnel syndrome in US working populations: pooled analysis of six prospective studies. Scandinavian Journal of Work, Environment, and Health2013;39(5):495-505. [DOI: 10.5271/sjweh.3351] [PMID: 23423472]">Dale 2013</a>). Incidence was 1.7/1000 person years in Finland, and it is associated with age and sex (<a href="./references#CD010003-bbs2-0159" title="PourmemariMH , HeliövaaraM , Viikari-JunturaE , ShiriR . Carpal tunnel release: lifetime prevalence, annual incidence, and risk factors. Muscle &amp; Nerve2018;58(4):497-502.">Pourmemari 2018</a>). People aged less than 25 years accounted for 2.4% of people presenting to Australian general practices with the condition between 2000 and 2009, compared to people aged 45 to 64 years who accounted for 45.5% of these cases (<a href="./references#CD010003-bbs2-0118" title="CharlesJ , FahridinS , BrittH . Carpal tunnel syndrome. Australian Family Physician2009;38(9):665. [PMID: 19893791]">Charles 2009</a>). CTS is reported to affect more women than men (<a href="./references#CD010003-bbs2-0153" title="PaduaL , CoraciD , ErraC , PazzagliaC , PaolassoI , LoretiC , et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurology2016;15(12):1273-84. [DOI: 10.1016/S1474-4422(16)30231-9] [PMID: 27751557]">Padua 2016</a>): 67% of CTS encounters at Australian general practices were in women (<a href="./references#CD010003-bbs2-0118" title="CharlesJ , FahridinS , BrittH . Carpal tunnel syndrome. Australian Family Physician2009;38(9):665. [PMID: 19893791]">Charles 2009</a>), and women in their fourth and fifth decades were four times more likely to suffer from CTS compared to men (<a href="./references#CD010003-bbs2-0116" title="AtroshiI , GummessonC , JohnssonR , OrnsteinE , RanstamJ , RosénI . Prevalence of carpal tunnel syndrome in a general population. JAMA1999;282(2):153-8. [PMID: 10411196]">Atroshi 1999</a>). CTS has been reported to occur more frequently in some professions, where there is frequent grasping, forceful grasping and flexed wrist postures, or exposure to vibration from hand‐held tools (<a href="./references#CD010003-bbs2-0157" title="PalmerK , HarrisC , CoggonD . Carpal tunnel syndrome and its relation to occupation: a systematic literature review. Occupational Medicine2007;57(1):57-66.">Palmar 2007</a>). </p> </section> <section id="CD010003-sec-0011"> <h3 class="title" id="CD010003-sec-0011">Description of the intervention</h3> <p>Treatment options for CTS are either surgical or non‐surgical. Carpal tunnel release (CTR) has been reported as the most common surgery in the United States, with more than 400,000 CTRs performed annually, with an estimated total cost to the healthcare system of $2 billion (<a href="./references#CD010003-bbs2-0120" title="ConcannonMJ , BrownfieldML , PuckettCL . The incidence of recurrence after endoscopic carpal tunnel release. Plastic and Reconstructive Surgery2000;105(5):1662-5. [PMID: 10809095]">Concannon 2000</a>; <a href="./references#CD010003-bbs2-0137" title="HuisstedeBM , HoogvlietP , RandsdorpMS , GlerumS , Van MiddelkoopM , KoesBW . Carpal tunnel syndrome. Part 1: Effectiveness of nonsurgical treatments - a systematic review. Archives of Physical Medicine and Rehabilitation2010;91(7):981-1004. [PMID: 20599038]">Huisstede 2010</a>). Surgical treatment is usually offered to those with advanced CTS, who have constant symptoms, severe sensory disturbance, or thenar motor weakness. Non‐surgical treatments are recommended as an initial treatment for those who have symptoms without evidence of denervation, cannot undergo surgery, or have intermittent symptoms of mild‐to‐moderate CTS. Non‐surgical treatment for CTS includes various interventions such as wrist splinting (with or without the hand included), taping the wrist (e.g. kinesiology taping), injections (including corticosteroid or platelet‐rich plasma (PRP)) into the carpal canal, exercises, yoga, therapeutic ultrasound, laser, acupuncture, activity or ergonomic modification, oral medication, and vitamins (<a href="./references#CD010003-bbs2-0124" title="DongC , SunY , QiY , ZhuY , WeiH , WuD , et al. Effect of platelet-rich plasma injection on mild or moderate carpal tunnel syndrome: an updated systematic review and meta-analysis of randomized controlled trials. BioMed Research International2020;2020:5089378. [DOI: 10.1155/2020/5089378]">Dong 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0146" title="MullerM , TsuiD , SchnurrR , Biddulph-Deisroth, HardJ , MacDermidJ . Effectiveness of hand therapy interventions in primary management of carpal tunnel syndrome: a systematic review. Journal of Hand Therapy2004;17(2):210-28. [PMID: 15162107]">Muller 2004</a>; <a href="./references#CD010003-bbs2-0148" title="O’ConnorD , PageMJ , MarshallSC , Massy-WestroppN . Ergonomic positioning or equipment for treating carpal tunnel syndrome. Cochrane Database of Systematic Reviews2012, Issue 1. Art. No: CD009600. [DOI: 10.1002/14651858.CD009600]">O'Connor 2012</a>; <a href="./references#CD010003-bbs2-0150" title="OstergaardPJ , MeyerMA , EarpBE . Non-operative treatment of carpal tunnel syndrome. Current Reviews in Musculoskeletal Medicine2020;13(2):141-7. [PMID: 10.1007/s12178-020-09616-0]">Ostergaard 2020</a>). </p> <p>Splinting generally immobilises the wrist joint by using an external orthosis. The splint usually leaves the fingers and thumb free to move, but some designs may include the fingers. The wrist is generally positioned in a neutral position in the splint; although, the precise angle has yet to be determined, between less than 20 degrees extension and closer to zero degrees has been found to be optimal (<a href="./references#CD010003-bbs2-0040" title="BurkeDT , BurkeMM , StewartGW , CambreA . Splinting for carpal tunnel syndrome: in search of the optimal angle. Archives of Physical Medicine and Rehabilitation1994;75(11):1241-4. [PMID: 7979936]">Burke 1994</a>). This splint may be worn either at night‐time only or during both the night and day. A thermoplastic splint may be custom fitted to the person with CTS by an occupational therapist, physiotherapist, or hand therapist. Sometimes, a softer, adjustable splint may be fitted; these splints can either be custom‐made or purchased off the shelf. Some splints may permit a restricted range of motion (<a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>). </p> </section> <section id="CD010003-sec-0012"> <h3 class="title" id="CD010003-sec-0012">How the intervention might work</h3> <p>In people with CTS, the wrist is usually splinted in a neutral position (i.e. with a straight wrist). When the wrist is in a neutral position, the pressure on the median nerve as it passes through the carpal tunnel is at its lowest. When the wrist is flexed or extended, the pressure increases (<a href="./references#CD010003-bbs2-0128" title="GelbermanRH , SzaboRM , MortensonMM . Carpal tunnel pressures and wrist position in patients with Colles fractures. Journal of Trauma, Injury, Infection and Critical Care1984;24(8):747-9. [PMID: 6471140]">Gelberman 1984</a>). As many people sleep with wrists in a flexed position, splinting at night maintains the wrist in the optimal position to reduce pressure within the carpal tunnel. Some have considered whether splinting the hand, in addition to the wrist, provides an additional benefit, as flexion of the fingers may further increase pressure in the carpal tunnel, through movement of the lumbricals, a group of small finger muscles, into the carpal tunnel (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>).  </p> </section> <section id="CD010003-sec-0013"> <h3 class="title" id="CD010003-sec-0013">Why it is important to do this review</h3> <p>CTS creates significant impairment in terms of pain and functional use of the hand. Work days missed due to CTS result in financial loss to both the individual and society. Workers with a CTS diagnosis missed a median of 28 days of work to recuperate (<a href="./references#CD010003-bbs2-0170" title="US Bureau of Labor Statistics. Nonfatal occupational injuries and illnesses requiring days away from work. www.bls.gov/news.release/pdf/osh2.pdf (accessed 1 September 2022).">U.S. Bureau of Labor Statistics 2016</a>). For individuals suffering from symptomatic CTS, the direct and indirect costs can average USD 40,000 per year for life (<a href="./references#CD010003-bbs2-0127" title="GabrielliAS , LesiakAC , FowlerJR . The direct and indirect costs to society of carpal tunnel release. Hand2020;15(2):NP26-30. [DOI: 10.117/1558944718810855]">Gabrielli 2020</a>). </p> <p>Following the publication of the previous versions of this review (<a href="./references#CD010003-bbs2-0175" title="O'ConnorD , MarshallS , Massy-WestroppN . Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2003, Issue 1. Art. No: CD003219. [DOI: 10.1002/14651858.CD003219]">O'Connor 2003</a>; <a href="./references#CD010003-bbs2-0176" title="PageMJ , Massy-WestroppN , O'ConnorD , PittV . Splinting for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2012, Issue 7. Art. No: CD010003. [DOI: 10.1002/14651858.CD010003]">Page 2012b</a>), which could not draw firm conclusions on the effect of splinting, the evidence base for all non‐surgical interventions for CTS has grown. Splinting is a common first‐line intervention for those with less severe symptoms or for those who do not wish to pursue more invasive treatment options, yet its efficacy is still unclear (<a href="./references#CD010003-bbs2-0176" title="PageMJ , Massy-WestroppN , O'ConnorD , PittV . Splinting for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2012, Issue 7. Art. No: CD010003. [DOI: 10.1002/14651858.CD010003]">Page 2012b</a>). Cochrane systematic reviews of local corticosteroid injections (<a href="./references#CD010003-bbs2-0144" title="MarshallSC , TardifG , AshworthNL . Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2007, Issue 2. Art. No: CD001554. [DOI: 10.1002/14651858.CD001554.pub2]">Marshall 2007</a>), surgical versus non‐surgical treatment (<a href="./references#CD010003-bbs2-0171" title="VerdugoRJ , SalinasRS , CastilloJ , CeaJG . Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD001552. [DOI: 10.1002/14651858.CD001552.pub2]">Verdugo 2008</a>), different surgical treatment options (<a href="./references#CD010003-bbs2-0164" title="ScholtenRJ , Van der MolenAM , UitdehaagBM , BouterLM , De VetHC . Surgical treatment options for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2007, Issue 4. Art. No: CD003905. [DOI: 10.1002/14651858.CD003905.pub3]">Scholten 2007</a>), therapeutic ultrasound (<a href="./references#CD010003-bbs2-0155" title="Page MJ, O'Connor D, Pitt V, Massy-Westropp N. Therapeutic ultrasound for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD009601. [DOI: 10.1002/14651858.CD009601.pub2]">Page 2013</a>), ergonomic interventions (<a href="./references#CD010003-bbs2-0148" title="O’ConnorD , PageMJ , MarshallSC , Massy-WestroppN . Ergonomic positioning or equipment for treating carpal tunnel syndrome. Cochrane Database of Systematic Reviews2012, Issue 1. Art. No: CD009600. [DOI: 10.1002/14651858.CD009600]">O'Connor 2012</a>), acupuncture (<a href="./references#CD010003-bbs2-0119" title="ChoiGH , WielandLS , LeeH , SimH , LeeMS , ShinBC . Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome. Cochrane Database of Systematic Reviews2018, Issue 12. Art. No: CD011215. [DOI: 10.1002/14651858.CD011215.pub2]">Choi 2018</a>), low‐level laser therapy (<a href="./references#CD010003-bbs2-0160" title="RankinIA , SargeanH , RehmanH , Selvan GurusamyK . Low-level laser therapy for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2017, Issue 8. Art. No: CD012765. [DOI: 10.1002/14651858.CD012765]">Rankin 2017</a>), exercise and mobilisation interventions (<a href="./references#CD010003-bbs2-0154" title="PageMJ , O'ConnorD , PittV , Massy‐WestroppN . Exercise and mobilisation interventions for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2012, Issue 6. Art. No: CD009899. [DOI: 10.1002/14651858.CD009899]">Page 2012a</a>) for CTS already exist, and up‐to‐date Cochrane systematic reviews of other non‐surgical interventions for CTS (e.g. splinting, oral drugs) are required. Given the personal and financial impact of CTS, there is a need to ascertain the efficacy of splinting for the treatment of CTS. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010003-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010003-sec-0014"></div> <p>To assess the effects (benefits and harms) of splinting for people with carpal tunnel syndrome. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010003-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010003-sec-0015"></div> <section id="CD010003-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010003-sec-0017"> <h4 class="title">Types of studies</h4> <p>All published and unpublished randomised controlled trials (RCTs) and quasi‐RCTs were eligible for inclusion regardless of publication status and whether they contained outcomes of interest or not. We did not use any language or publication date restrictions or limit the setting of the trials. </p> </section> <section id="CD010003-sec-0018"> <h4 class="title">Types of participants</h4> <p>All study participants had a diagnosis of carpal tunnel syndrome (CTS), as defined by the authors of each study. We excluded studies that included participants who had previous surgery for CTS. </p> </section> <section id="CD010003-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included all splinting interventions, including static (immobilisation), dynamic (allowing a limited range of motion within the splint), or splints aimed at stretching the transverse carpal ligament. </p> <p>Comparators included no treatment, placebo and other non‐surgical interventions. We also included studies comparing different splinting regimens (i.e. different time periods, or night versus day versus full time). </p> <p>We excluded the following. </p> <p> <ul id="CD010003-list-0001"> <li> <p>Studies comparing splinting with other non‐surgical treatments that did not have plausible biological mechanism of action to modify the disease or interventions that could be considered as symptom‐modifying interventions. These included, for example, acupuncture, electroacupuncture, yoga, or topical flax seed oil, interferential current, transcutaneous electrical nerve stimulation and phonophoresis; </p> </li> <li> <p>Studies in which the effect of splinting could not be isolated from the other treatment modalities. That is, splinting was delivered alongside another active treatment and the control group did not receive the same active co‐intervention; </p> </li> <li> <p>Studies comparing splinting with surgical treatment (as these are reviewed elsewhere, <a href="./references#CD010003-bbs2-0171" title="VerdugoRJ , SalinasRS , CastilloJ , CeaJG . Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD001552. [DOI: 10.1002/14651858.CD001552.pub2]">Verdugo 2008</a>); </p> </li> <li> <p>Studies comparing various splint designs since these comparisons do not inform stakeholders if splints can provide benefits in people with CTS. Moreover, these comparison yield treatment estimates between a specific type of splints and these estimates are likely not applicable. However, these comparisons may be included in future updates if splinting is found to be efficacious. </p> </li> </ul> </p> </section> <section id="CD010003-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>The outcomes reported in this review have been modified from the original review (<a href="./references#CD010003-bbs2-0175" title="O'ConnorD , MarshallS , Massy-WestroppN . Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2003, Issue 1. Art. No: CD003219. [DOI: 10.1002/14651858.CD003219]">O'Connor 2003</a>) and its most recent update (<a href="./references#CD010003-bbs2-0176" title="PageMJ , Massy-WestroppN , O'ConnorD , PittV . Splinting for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2012, Issue 7. Art. No: CD010003. [DOI: 10.1002/14651858.CD010003]">Page 2012b</a>); see <a href="#CD010003-sec-0210">Differences between protocol and review</a>. For this update, we used CTS symptoms (continuous outcome) as the primary outcome, since global improvement is infrequently used and the Boston Carpal Tunnel Questionnaire (BCTQ) is a validated responsive measure used in most studies (<a href="./references#CD010003-bbs2-0142" title="LeiteJC , Jerosch-HeroldC , SongF . A systematic review of the psychometric properties of the Boston Carpal Tunnel Questionnaire. BMC Musculoskeletal Disorders2006;7:78.">Leite 2006</a>; <a href="./references#CD010003-bbs2-0147" title="MultanenJ , YlinenJ , KarjalainenT , IkonenJ , HäkkinenA , RepoJP . Structural validity of the Boston Carpal Tunnel Questionnaire and its short version, the 6-Item CTS symptoms scale: a Rasch analysis one year after surgery. BMC Musculoskeletal Disorders2020;21(1):609.">Multanen 2020</a>). We prioritised the BCTQ Symptoms Severity Scale for symptoms and used pain (Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS)) as a secondary source of data if the BCTQ was not measured or reported (5 of 11, or 45% items in the BCTQ Symptom Severity Scale are measuring pain). </p> <p>Furthermore, we did not consider the electrodiagnostic outcomes (e.g. sensory or motor nerve conduction velocity) in this update, as their clinical relevance is unclear (<a href="./references#CD010003-bbs2-0165" title="SchrijverHM , GerritsenAA , StrijersRL , UitdehaagBM , ScholtenRJ , De Vet HenricaCW , et al. Correlating nerve conduction studies and clinical outcome measures on carpal tunnel syndrome: lessons from a randomized controlled trial. Journal of Clinical Neurophysiology2005;22(3):216-21.">Schrijver 2005</a>; see <a href="#CD010003-sec-0210">Differences between protocol and review</a>). </p> <p>We planned to prioritise one‐year follow‐up for long‐term outcomes, but since no studies reported multiple long‐term time points, we did not have to choose between various time points. </p> <section id="CD010003-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010003-list-0002"> <li> <p>CTS symptoms (prioritising BCTQ Symptom Severity Scale) at:</p> <ul id="CD010003-list-0003"> <li> <p>Short term (up to 3 months prioritising the time closest to 3 months); and</p> </li> <li> <p>Long term (over 3 months).</p> </li> </ul> </li> </ul> </p> </section> <section id="CD010003-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010003-list-0004"> <li> <p>Function (CTS‐specific or hand‐specific patient‐reported outcome measure) at:</p> <ol id="CD010003-list-0005"> <li> <p>Short term (up to 3 months, prioritising the time closest to 3 months); and</p> </li> <li> <p>Long term (over 3 months).</p> </li> </ol> </li> <li> <p>Overall improvement of symptoms (dichotomised from global scale (e.g. Likert) or binary outcome categorising participants as improved) at: </p> <ol id="CD010003-list-0006"> <li> <p>Short term (up to 3 months, prioritising the time closest to 3 months); and</p> </li> <li> <p>Long term (over 3 months).</p> </li> </ol> </li> <li> <p>Health‐related quality of life at:</p> <ol id="CD010003-list-0007"> <li> <p>Short term (up to 3 months, prioritising the time closest to 3 months); and</p> </li> <li> <p>Long term (over 3 months).</p> </li> </ol> </li> <li> <p>Adverse effects at the final time point of the study.</p> </li> <li> <p>Referral for surgery (number of participants who were referred to surgery or operated, at the final time point of the study). </p> </li> </ol> </p> </section> </section> </section> <section id="CD010003-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010003-sec-0024"> <h4 class="title">Electronic searches</h4> <p>On 11 December 2020 and 12 December 2021, the Cochrane Neuromuscular Information Specialist searched the following databases for this version of the review: </p> <p> <ul id="CD010003-list-0008"> <li> <p>the Cochrane Neuromuscular Specialised Register via the Cochrane Register of Studies (CRS‐Web) (until Search Date; <a href="./appendices#CD010003-sec-0195">Appendix 1</a>) </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Register of Studies (CRS‐Web) (until Search Date; <a href="./appendices#CD010003-sec-0196">Appendix 2</a>) </p> </li> <li> <p>MEDLINE (1946 to 10 December 2021; <a href="./appendices#CD010003-sec-0197">Appendix 3</a>) </p> </li> <li> <p>Embase (1974 to Week 49 2021; <a href="./appendices#CD010003-sec-0198">Appendix 4</a>) </p> </li> <li> <p>AMED (1985 to December 2021; <a href="./appendices#CD010003-sec-0199">Appendix 5</a>) </p> </li> <li> <p>CINAHL Plus (1937 to 12 December 2021; <a href="./appendices#CD010003-sec-0200">Appendix 6</a>) </p> </li> <li> <p>ClinicalTrials.Gov (until Search Date; <a href="./appendices#CD010003-sec-0201">Appendix 7</a>) </p> </li> <li> <p>WHO ICTRP (until Search Date; <a href="./appendices#CD010003-sec-0202">Appendix 8</a>) </p> </li> </ul> </p> <p>There was no limitation to date of publication, language, publication status or document type. </p> </section> <section id="CD010003-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We browsed the reference lists of all included trials and relevant reviews for further relevant studies. </p> </section> </section> <section id="CD010003-sec-0026"> <h3 class="title" id="CD010003-sec-0026">Data collection and analysis</h3> <p>The review authors followed the recommended strategies for data collection and analysis as documented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010003-bbs2-0136" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Higgins 2021</a>). </p> <section id="CD010003-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Review authors (TK, VL, SP) working in pairs independently selected trials for possible inclusion based on the review inclusion criteria (study is an RCT or quasi‐RCT; study investigates splinting versus other non‐surgical treatment, no treatment, or placebo, or different splinting regimens for CTS). We then retrieved trials that were potentially eligible for full‐text evaluation to determine whether they met the inclusion criteria. The authors resolved any disagreement via discussion. We also searched PubMed for relevant errata or retraction statements for the included studies, and collated several references related to the same study.  </p> </section> <section id="CD010003-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Review authors (TK, VL, SP, MP, NMW, DOC) working in pairs independently extracted data from each study using a standardised data extraction form. Authors resolved any discrepancies by discussion. We pilot‐tested the data extraction form and modified it accordingly before use. We recorded the following details. </p> <p> <ul id="CD010003-list-0009"> <li> <p>Participant details (number of participants randomised and analysed, sex, age, duration of symptoms). </p> </li> <li> <p>Inclusion and exclusion criteria, as well as CTS diagnostic criteria.</p> </li> <li> <p>Types of interventions used and details of the comparator.</p> </li> <li> <p>Outcomes, including the type and timing of measures used.</p> </li> <li> <p>Source of funding and investigators' conflicts of interest.</p> </li> </ul> </p> <p>One review author (VL) compiled all data and entered the data into RevMan Web.</p> </section> <section id="CD010003-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Review authors (TK, VL, SP, MP, NMW, DOC) working in pairs independently assessed the risk of bias of the included studies using The Cochrane Collaboration's risk of bias tool, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010003-bbs2-0135" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>). We assessed the following domains for risk of bias based on information extracted from the reports of the included studies. </p> <p> <ul id="CD010003-list-0010"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data (defined separately for data measured at 3 months or less, and after 3 months). </p> </li> <li> <p>Selective reporting.</p> </li> <li> <p>Other sources of bias. (e.g. inappropriate unit of analysis). </p> </li> </ul> </p> <p>The review authors rated each domain as being at 'low risk of bias', 'unclear risk of bias' or 'high risk of bias'. We resolved any discrepancies through discussion. </p> </section> <section id="CD010003-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used Cochrane Review Manager (RevMan) software to perform data analyses (<a href="./references#CD010003-bbs2-0162" title="Review Manager. Version 5.4. The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We expressed results as the risk ratio (RR) and 95% confidence interval (CI) for dichotomous outcomes and mean difference (MD) with 95% CI for continuous outcomes when the same measurement tool was used to measure the same outcome across all studies in the meta‐analysis. </p> <p>When studies used different measurement instruments for the same outcome domain, we used a standardised mean difference (SMD) as a summary measure. We then back‐transformed the SMD to the typical outcome measure (multiplying the SMD and its 95% CI by a typical among‐person standard deviation (SD) (e.g. the SD of the control group at baseline from the most representative trial)). When the outcome measures had a different direction in a meta‐analysis (e.g. higher versus lower is better), we reversed the values so that the direction was the same in all studies.  </p> <p>For dichotomous outcomes, we calculated the number needed to treat for an additional beneficial outcome (NNTB) or number needed to treat for an additional harmful outcome (NNTH) as 1/risk difference when the analysis showed benefit or harm for splinting. NNTB are reported in whole numbers, rounded up. </p> <p>We set statistical significance at P &lt; 0.05 for all outcomes.</p> </section> <section id="CD010003-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We sought information about the unit of randomisation used (i.e. wrists or participants, where participants with bilateral CTS received the same intervention for both wrists). In studies that randomised wrists, we sought information about whether each participant's wrist was allocated to different treatments, or whether there was no constraint that each participant's wrist be allocated to different treatments. We preferred participant‐level data whenever it was available. If the authors had randomised wrists and did not report results at the participant level and had not adjusted the analyses for clustering, we considered this a possible source of bias in the 'other bias' domain. </p> <p>In case of multi‐arm studies, we compared the splinting arm with other eligible arms in separate analyses, avoiding double‐counting the same participants in the total number of the analysed participants.  </p> </section> <section id="CD010003-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>The review authors sought relevant missing information about the study design or results from the study investigators, where possible. We noted in the <a href="./references#CD010003-sec-0212" title="">Characteristics of included studies</a> tables when authors were contacted for additional data. When SDs of the mean were not reported, we calculated them based on the standard error of the mean, 95% CIs of the mean, reported P values, interquartile range, or range. When the SD was calculated using other measures, we noted this in the <a href="./references#CD010003-sec-0212" title="">Characteristics of included studies</a> table in the notes section. </p> </section> <section id="CD010003-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical diversity by determining whether the characteristics of participants, interventions, outcome measures and timing of outcome measurement were similar across studies. Statistical heterogeneity was assessed by visual inspection of the forest plots and using the Chi<sup>2</sup> statistic and the I<sup>2</sup> test (<a href="./references#CD010003-bbs2-0134" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in meta-analysis. Statistics in Medicine2002;21(11):1539-58.">Higgins 2002</a>). We interpreted the I<sup>2</sup> statistic using the following as an approximate guide (<a href="./references#CD010003-bbs2-0122" title="DeeksJJ , HigginsJP , Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Deeks 2021</a>). </p> <p> <ul id="CD010003-list-0011"> <li> <p>0% to 40% might not be important heterogeneity.</p> </li> <li> <p>30% to 60% may represent moderate heterogeneity.</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity.</p> </li> <li> <p>75% to 100% may represent considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD010003-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>To assess publication bias, we intended to generate funnel plots if the review included at least 10 studies examining the same treatment comparison (<a href="./references#CD010003-bbs2-0156" title="PageMJ , HigginsJP , SterneJA . Chapter 13: Assessing risk of bias due to missing results in a synthesis. In:Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Page 2021</a>). To assess outcome reporting bias, we searched protocols of trials on the clinical trials register (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>), and at the International Clinical Trials Registry Platform of the World Health Organization (<a href="http://apps.who.int/trialssearch" target="_blank">apps.who.int/trialssearch</a>), to compare with the corresponding published RCTs (<a href="./references#CD010003-bbs2-0125" title="DwanK , AltmanDG , ArnaizJA , BloomJ , ChanAW , CroninE , et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLOS One2008;3(8):e3081. [PMID: 18769481]">Dwan 2008</a>; <a href="./references#CD010003-bbs2-0126" title="DwanK , AltmanDG , CresswellL , BlundellM , GambleCL , WilliamsonPR . Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database of Systematic Reviews2011, Issue 1. Art. No: MR000031. [DOI: 10.1002/14651858.MR000031.pub2]">Dwan 2011</a>). When the study was not registered, or we could not identify a published protocol, we deemed the study to be at unclear risk of selective reporting bias. </p> </section> <section id="CD010003-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We defined the following review questions based on the protocol in the previous version and based on the identified comparisons as follows. </p> <p> <ul id="CD010003-list-0012"> <li> <p>Splint versus no active intervention</p> </li> <li> <p>Splint versus corticosteroid injection</p> </li> <li> <p>Splint versus oral steroid</p> </li> <li> <p>Splint plus corticosteroid injection versus corticosteroid injection</p> </li> <li> <p>Splint versus exercise</p> </li> <li> <p>Stretching splint versus stretching exercises</p> </li> <li> <p>Splint versus kinesiology taping</p> </li> <li> <p>Splint versus rigid tape</p> </li> <li> <p>Splint versus platelet‐rich plasma (PRP)</p> </li> <li> <p>Splint versus extracorporeal shockwave therapy (ESWT)</p> </li> <li> <p>Dynamic splint plus rehabilitation versus rehabilitation</p> </li> <li> <p>Splint for six weeks versus splint for 12 weeks</p> </li> <li> <p>Splint for six weeks versus splint for six months</p> </li> <li> <p>Night‐time splinting versus full‐time splinting</p> </li> </ul> </p> <p>We pooled the results of studies with similar characteristics (participants, interventions, outcome measures and timing of outcome measurement) in a random‐effects meta‐analysis (inverse variance method, DerSimonian‐Laird between‐study variance estimator, Wald‐type method for calculating the 95% CI of the summary effect) for each comparison to provide effect estimates for each outcome that was measured and reported. The primary analysis included all eligible studies. Where we could not pool data, we presented the results as reported by the authors narratively.  </p> <p>We used minimal clinically important difference (MCID) values to assess the clinical importance of differences in patient‐reported outcomes. A wide range of values have been reported as the MCID for the BCTQ Symptom Severity Scale (0.16 to 1.45) and Functional Status Scale (0.47 to 1.6) (<a href="./references#CD010003-bbs2-0123" title="De KleermaekerFG , BoogaartsHD , MeulsteeJ , VerhagenWI . Minimal clinically important difference for the Boston Carpal Tunnel Questionnaire: new insights and review of literature. Journal of Hand Surgery, European Volume2018;44(3):283-9.">De Kleermaeker 2018</a>). We considered a one‐point difference as MCID for the BCTQ Symptom Severity Scale and 0.7 points for the Functional Status Scale (<a href="./references#CD010003-bbs2-0141" title="KimJK , JeonSH . Minimal clinically important differences in the Carpal Tunnel Questionnaire after carpal tunnel release. Journal of Hand Surgery. European Volume2013;38(1):75-9.">Kim 2013</a>). Furthermore, we used 0.074 points difference as MCID for the EQ‐5D (<a href="./references#CD010003-bbs2-0172" title="WaltersSJ , BrazierJE . Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research2005;6:1523-32. [DOI: 10.1007/s11136-004-7713-0]">Walters 2005</a>).  </p> </section> <section id="CD010003-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed no subgroup analyses in this update, as data were not available, but we planned to do subgroup analyses regarding the primary outcome according to the severity of CTS symptoms and sex as per the previous review protocol. </p> <p> <ul id="CD010003-list-0013"> <li> <p>Severity of CTS symptoms: early (E), intermediate (I) and advanced (A) symptoms (<a href="./references#CD010003-bbs2-0168" title="SzaboRM , MadisonM . Carpal tunnel syndrome. Orthopedic Clinics of North America1992;23(1):103-9. [MEDLINE: 92107436]">Szabo 1992</a>) </p> </li> <li> <p>Sex: male and female</p> </li> </ul> </p> </section> <section id="CD010003-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>To assess the robustness of our findings, we planned sensitivity analyses for studies with low risk of bias in all domains versus those with high or unclear; and low risk of selection bias versus high or unclear risk for the primary comparison (splint versus no active treatment). Since all studies were at high risk of detection and performance bias, we only conducted the latter sensitivity analysis regarding the primary outcome (CTS symptoms). </p> </section> <section id="CD010003-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We presented all outcomes for the primary comparison (splint compared to no active treatment) in the <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a> and in the additional table (<a href="#CD010003-tbl-0002">Table 1</a>). We included one effect estimate for each of our primary and secondary outcomes (see <a href="#CD010003-sec-0020">Types of outcome measures</a>) and included an overall grading of the evidence related to each of the main outcomes, using the GRADE approach (<a href="./references#CD010003-bbs2-0166" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP ,  et al, Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from: training.cochrane.org/handbook/archive/v5.1.">Schünemann 2017</a>). For binary outcomes, we presented the assumed control group risk and relative risk in the splinting group. We also calculated and noted the absolute risk difference between the intervention and control group, as calculated in GRADEpro GDT (<a href="./references#CD010003-bbs2-0131" title="GRADEpro Guideline Development Tool. McMaster University and Evidence Prime, 2021. Available from gradepro.org.">GRADEpro GDT 2021</a>), expressed as a percentage. For continuous outcomes, we reported the weighted mean value for the control group (i.e. mean1 * sample size1 + mean2 * sample size2 + meanx * sample sizex/sum of sample sizes). The absolute difference is expressed as the mean difference (MD) with 95% confidence intervals. We also calculated the relative difference (relative to the scale of the measurement instrument; i.e. MD divided by the scale of the measure and expressed as a percentage). </p> <div class="table" id="CD010003-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome ‐ outcomes that are not presented in the summary of findings table</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome ‐ outcomes that are not presented in the summary of findings table</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> carpal tunnel syndrome<br/><b>Setting: </b> outpatient clinics in Italy, Thailand and Turkey; hospital clinic in Australia; education and research hospital in Turkey<br/><b>Intervention:</b> SPLINT<br/><b>Comparison:</b> NO ACTIVE TREATMENT </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NO ACTIVE TREATMENT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with SPLINT</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional status (Boston CTS questionnaire) ‐ short‐term improvement: &lt; 3 months. Scale: 1 to 5, higher is worse </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean function was <b>1.97</b> points </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.24 points better</b><br/>(0.44 better to 0.03 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Splint probably does not improve hand function in the short term. Absolute difference 6% better (11% better to 0.75% better) with splint </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall improvement ‐ long‐term improvement: &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable. We are uncertain about the effect.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life ‐ short‐term improvement: &lt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable. We are uncertain about the effect.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio; <b>CTS</b>: carpal tunnel syndrome </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Downgraded for high risk of bias in the included studies (lack of blinding) </p> </div> </div> <p>Two review authors (TK, VL) assessed the certainty of the evidence as 'high', 'moderate', 'low', or 'very low' using the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the body of evidence. We used GRADEpro software to prepare the Summary of findings table (<a href="./references#CD010003-bbs2-0131" title="GRADEpro Guideline Development Tool. McMaster University and Evidence Prime, 2021. Available from gradepro.org.">GRADEpro GDT 2021</a>). We reported decisions to downgrade the certainty of evidence in the footnotes of the Summary of findings table and in the 'Results' section for each outcome. For comparisons and outcomes that were not included in the Summary of Findings table, the certainty of evidence was reported in the results section. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010003-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010003-sec-0039"></div> <section id="CD010003-sec-0040"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD010003-sec-0212" title="">Characteristics of included studies</a>; <a href="./references#CD010003-sec-0213" title="">Characteristics of excluded studies</a>. </p> <section id="CD010003-sec-0041"> <h4 class="title">Results of the search</h4> <p>Eight of the 19 trials included in the previous Cochrane Review met the inclusion criteria for this updated review due to the restriction in scope from the original review (<a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>, <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>). One study awaiting classification in the previous Cochrane Review is now included in the updated review (<a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>). </p> <p>The search was updated on 12 December 2021, and we identified 1643 new records, assessed 81 potentially eligible full texts and finally included 20 new studies (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>) (<a href="#CD010003-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010003-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="1 ‐ reasons for exclusion: in 5 studies the effect of splinting cannot be isolated from that of the other intervention delivered alongside it; in 29 studies splint applied to each study group; 7 studies compare treatment methods which we defined as not relevant for this review; 5 studies were not a randomised trial" data-id="CD010003-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>1 ‐ reasons for exclusion: in 5 studies the effect of splinting cannot be isolated from that of the other intervention delivered alongside it; in 29 studies splint applied to each study group; 7 studies compare treatment methods which we defined as not relevant for this review; 5 studies were not a randomised trial </p> </div> </div> </div> <p>Six studies are currently awaiting assessment for the following reasons: </p> <p> <ol id="CD010003-list-0014"> <li> <p>It is unclear if the study is a randomised controlled trial (RCT) (<a href="./references#CD010003-bbs2-0103" title="BhuvaVD , JagtapV . Effect of customized splint and soft tissue mobilization exercises in carpal tunnel syndrome. Indian Journal of Physiotherapy &amp; Occupational Therapy2019;13(3):121-6. ">Bhuva 2019</a>; <a href="./references#CD010003-bbs2-0106" title="RiasiH , Rajabpour SanatiA , SalehiF , SalehianH , GhaemiK . Analyzing the therapeutic effects of short wrist splint in patients with carpal tunnel syndrome (CTS) under ibuprofen treatment from an EMG-NCV perspective. Journal of Medicine and Life 2015;8(Special Issue 4):154-8. ">Riasi 2015</a>);  </p> </li> <li> <p>Results are not yet published in a format that allows for risk of bias assessment and data extraction (<a href="./references#CD010003-bbs2-0102" title="BaklaciK . Long-term effectiveness of physical therapy modalities in carpal tunnel syndrome. Internal Medicine Journal2015;45(Suppl 2):12. ">Baklaci 2015</a>; <a href="./references#CD010003-bbs2-0107" title="ACTRN12613000140752. A randomised clinical trial of physiotherapy, therapeutic ultrasound and hand splinting for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12613000140752 (first received 6 February 2013). SoonB , VicenzinoB , PlumbeL , CoppietersM . Randomised clinical trial on efficacy of combining hand splinting with physiotherapy or ultrasound treatment for patients with carpal tunnel syndrome. Physiotherapy (United Kingdom)2015;101:eS1422-eS3. ">Soon 2015</a>);  </p> </li> <li> <p>Two clinical trials from the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal were marked as completed (<a href="./references#CD010003-bbs2-0104" title="IRCT2014020416485N1. Therapeutic effect of ultrasound-guided local steroid injection with hydro-dissection in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014020416485N1 (first received 4 May 2014). ">IRCT2014020416485N1</a>; <a href="./references#CD010003-bbs2-0105" title="ISRCTN22916517. Comparison of wrist splints and steroid injection for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN22916517 (first received 12 September 2003). ">ISRCTN22916517</a>), but we found no published articles. </p> </li> </ol> </p> <p>We identified seven ongoing studies that seemed to meet our inclusion criteria (<a href="./references#CD010003-bbs2-0108" title="AtroshiI , TadjerbashiK , McCabeSJ , RanstamJ . Treatment of carpal tunnel syndrome with wrist splinting: study protocol for a randomized placebo-controlled trial. Trials2019;20(1):531. [DOI: https://doi.org/10.1186/s13063-019-3635-6]ISRCTN81836603. Evaluation of wrist splinting for the treatment of carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN81836603 (first received 2 May 2018). ">Atroshi 2019</a>; and six clinical trials from World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal and ClinicalTrials.gov: <a href="./references#CD010003-bbs2-0109" title="IRCT20120716010297N5. The long-term effect of low level laser therapy on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT20120716010297N5 (first received 20 June 2018). ">IRCT20120716010297N5</a>; <a href="./references#CD010003-bbs2-0110" title="IRCT20200219046552N1. Comparison of local corticosteroid injection and high-intensity laser outcomes in moderate carpal tunnel syndrome (CTS). who.int/trialsearch/Trial2.aspx?TrialID=IRCT20200219046552N1 (first received 29 March 2020). ">IRCT20200219046552N1</a>; <a href="./references#CD010003-bbs2-0111" title="JPRN-UMIN000017952. Nerve gliding exercise for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000017952 (first received 1 July 2015). ">JPRN‐UMIN000017952</a>; <a href="./references#CD010003-bbs2-0112" title="NCT04017390. The effect of theraworx foam in carpal tunnel syndrome. clinicaltrials.gov/show/NCT04017390 (first received 12 July 2019). ">NCT04017390</a>; <a href="./references#CD010003-bbs2-0113" title="NCT04515966. A comparison of ultrasound-guided steroid injection with wrist splint in carpal tunnel syndrome. clinicaltrials.gov/show/NCT04515966 (first received 17 August 2020). ">NCT04515966</a>; <a href="./references#CD010003-bbs2-0114" title="NCT04993703. Effect of kinesiotaping and night splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/ct2/show/NCT04993703 (first received 6 August 2021). ">NCT04993703</a>). </p> <p>A flow diagram of the study selection process is presented in <a href="#CD010003-fig-0001">Figure 1</a>. </p> </section> <section id="CD010003-sec-0042"> <h4 class="title">Included studies</h4> <p>Twenty‐nine RCTs, published between and 2000 and 2021, were included in this review.</p> <section id="CD010003-sec-0043"> <h5 class="title">Participants</h5> <p>The 29 included studies comprised 1937 randomised participants. Some participants had bilateral carpal tunnel syndrome (CTS) and, thus, the studies included 2362 wrists. Three‐hundred‐and‐thirty (19%) participants were men, 1372 (81%) were women, and 235 randomised participants (from 9 studies) did not report the sex distribution (<a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>). </p> <p>The trials size varied from 21 to 234 participants. Participants' mean age ranged between 42 and 60 years; one study (<a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>) did not report the age of participants. The mean duration of CTS symptoms varied from seven weeks to five years in 16 studies; 13 studies did not report the mean duration of symptoms (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>). Most trialists excluded people with diabetes or rheumatoid arthritis, except for seven studies that included participants with these health conditions (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). Most of the studies reported having pregnancy as exclusion criteria (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). One study specifically focused on pregnant women as their population of interest (<a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>). </p> <p>Participants in the included studies started with moderate impairment measured by the Boston Carpal Tunnel Questionnaire (BCTQ) Symptom Severity Scale (1 to 5, higher is worse) or Functional Status Scale (1 to 5, higher is worse). The mean symptom severity score at baseline was 2.79 (range from 1.66 to 3.65, data available n = 1689, 23 studies), and the mean functional status score was 2.37 (range from 1.25 to 4.05, data available n = 1577, 22 studies). </p> </section> <section id="CD010003-sec-0044"> <h5 class="title">Interventions</h5> <section id="CD010003-sec-0045"> <h6 class="title"><i>Splint wear regimen and duration</i> </h6> <p>Treatments varied in duration, type of splint and splint‐wearing regimen. The duration of splint use ranged from one week of nocturnal use (<a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>), to one year of nocturnal use (<a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>), with about half of studies (15 of 29) prescribing a regimen of between two and six weeks. The most common regimen was nocturnal wear (23 of 29 studies, in 8 of which also daytime wear was recommended whenever possible). One study specifically compared night‐time use with full‐time use (<a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>). One study did not report how the splint was worn (<a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>), and in two studies the duration of splint use was unclear (<a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). </p> <p>Fifteen studies reported that they monitored compliance/adherence with splint use (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). The reported compliance/adherence to splint use mainly varied from full to partial (we presented specific information for each study in the Notes section of <a href="./references#CD010003-sec-0212" title="">Characteristics of included studies</a>). Some studies excluded participants who did not comply with splint use from follow‐up (<a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>). One study formed the control group from the subset of participants who did not comply with the splint regimen (<a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>), but we combined data from the splinting group and this control group to perform an intention‐to‐treat analysis. </p> </section> <section id="CD010003-sec-0046"> <h6 class="title"><i>Types of splints</i> </h6> <p>Splints were both custom‐made and commercially available. All splints involved wrist support at angles of 'neutral' to 20° of wrist extension. Most splints did not describe joint involvement other than the wrist, except for the MANU hand brace developed by <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a> (fingers 2 to 5 were splinted), and in some cases the MCP joints were also splinted in a 'neutral' position. In one study, instead of immobilising the wrist, the 'Dynasplint' applied pressure across the base of the hand in order to stretch the transverse carpal ligament (<a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). One study used a "limited dynamic wrist splint" that allowed the wrist to move between 15º of flexion and extension without radial or ulnar deviation of the wrist (<a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>). </p> </section> <section id="CD010003-sec-0047"> <h6 class="title"><i>Co‐interventions</i> </h6> <p>Ten studies measured the effect of splints delivered with some other non‐surgical intervention: education (<a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>), ergonomic education (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>), an exercise programme (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>), a physical therapy programme (consisting of heat application‐ultrasound‐transcutaneous electrical nerve stimulation (TENS) and strengthening exercises) (<a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>), usual rehabilitation including activity or ergonomic modifications, nerve and tendon gliding exercises, massage, carpal bones and nerve mobilisations, stretches of the upper extremity and flexor retinaculum (<a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>), tendon and nerve gliding exercises (<a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>), corticosteroid injection (<a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>), NSAID, B<sub>1</sub> and B<sub>6</sub>, paraffin bath, ultrasound underwater and grip exercise (<a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>). </p> </section> </section> <section id="CD010003-sec-0048"> <h5 class="title">Outcomes</h5> <section id="CD010003-sec-0049"> <h6 class="title">Primary outcome: CTS symptoms</h6> <p>We extracted symptom severity scores of the BCTQ (scale 1 to 5, higher is worse; <a href="./references#CD010003-bbs2-0143" title="LevineDW , SimmonsBP , KorisMJ , DaltroyLH , HohlGG , FosselAH , et al. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. Journal of Bone and Joint Surgery. American Volume1993;75(11):1585-92.">Levine 1993</a>), whenever possible. In one study (<a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>), symptoms were measured by the Neurological Symptom Score (scale 0 to 3, higher is worse). Symptom severity was measured in 25 studies (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). However, two of the studies did not report the scores and did not respond to queries (<a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>). </p> </section> <section id="CD010003-sec-0050"> <h6 class="title">Secondary outcomes</h6> <p>Secondary outcomes were function; overall improvement; health‐related quality of life score (HRQoL); adverse effects; and referral for surgery. </p> <section id="CD010003-sec-0051"> <p><b>Function</b></p> <p>The most commonly assessed secondary outcome was the BCTQ functional status score (scale 1 to 5, higher is worse), measured in 23 studies (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>).  </p> </section> <section id="CD010003-sec-0052"> <p><b>Overall improvement</b></p> <p>Overall improvement, using any measure where participants indicate the overall/global intensity of their complaints compared with baseline, was reported in three studies (<a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>). <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a> reported satisfaction score on a five‐point scale.  </p> </section> <section id="CD010003-sec-0053"> <p><b>HRQoL</b></p> <p>Two studies reported HRQoL (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a> by EQ‐5D‐5L and <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a> by Health Assessment Questionnaire). </p> </section> <section id="CD010003-sec-0054"> <p><b>Adverse events</b></p> <p>Adverse effects of splint and other non‐surgical interventions for CTS were measured and reported in nine studies (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>).  </p> </section> <section id="CD010003-sec-0055"> <p><b>Referral for surgery</b></p> <p>Referral for surgery was measured in nine studies (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). However, this was incompletely reported in <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>. </p> <p>Twenty‐eight studies measured outcomes at short‐term follow‐up (up to 3 months after treatment). Eight studies measured outcomes at long‐term follow‐up (more than 3 months after treatment) (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). </p> </section> </section> </section> <section id="CD010003-sec-0056"> <h5 class="title">Unit of analysis</h5> <p>The unit of analysis was the wrist in 11 studies (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>), and some or all participants in these studies had bilateral CTS.  </p> <p> <ol id="CD010003-list-0015"> <li> <p>In seven of these studies (<a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>), randomisation occurred at the level of participants, and the same intervention was delivered to both wrists. </p> </li> <li> <p>In <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>, the authors performed double randomisation at the wrist level (firstly to laser/placebo laser groups and then the same participants to splint/no splint groups), and each participant's wrists could be allocated to the same or different treatments. </p> </li> <li> <p>It was unclear in three studies whether participants were randomised at the level of the person or the wrist or if people with bilateral CTS received the same or different interventions for each wrist (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>). </p> </li> </ol> </p> <p>The unit of analysis was the participant in 18 studies (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>), even if some or all participants in these studies had bilateral CTS.  </p> <p> <ol id="CD010003-list-0016"> <li> <p>In 11 of these studies, only one side was assessed at follow‐up for people with bilateral CTS (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>). <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a> also permitted treatment of the non‐study hand using the research clinical protocol. </p> </li> <li> <p>In three studies, some included participants had bilateral CTS; however, no clear information was provided with respect to how the trial investigators dealt with and accounted for bilateral CTS in their study design and analysis (outcomes were analysed at the participant level) (<a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>). </p> </li> <li> <p>It was unclear in three studies whether any participant had bilateral CTS and how the study dealt with bilateral CTS if such was present (outcomes were analysed at the participant level) (<a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). </p> </li> <li> <p><a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a> included only people with unilateral CTS in the study and analysis. </p> </li> </ol> </p> </section> <section id="CD010003-sec-0057"> <h5 class="title">Funding</h5> <p>Eight studies reported receiving financial support through various sources (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). Three studies declared that no financial support was received (<a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>). Eighteen studies did not report information related to the funding (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>). </p> </section> </section> <section id="CD010003-sec-0058"> <h4 class="title">Excluded studies</h4> <p>In total, we excluded 72 studies after review of the full publication. Reasons for exclusion of studies are given in the '<a href="./references#CD010003-sec-0213" title="">Characteristics of excluded studies</a>' table. The most common reasons for exclusion were:  </p> <p> <ol id="CD010003-list-0017"> <li> <p>Both groups followed a similar splinting regimen, thus the effect of splinting could not be assessed. </p> </li> <li> <p>The effect of splinting could not be isolated from that of the other concomitant treatment(s) delivered alongside (i.e. splint was delivered with another treatment that was not applied in the control group). </p> </li> <li> <p>The study compared treatment methods not relevant for this review (see <a href="#CD010003-sec-0017">Types of studies</a>): splint and nerve‐ and tendon‐gliding exercises versus gabapentin and nerve‐ and tendon‐gliding exercises; splint versus surgery; splint versus yoga; splint versus acupuncture; splint versus interferential current; splint versus transcutaneous electrical nerve stimulation; splint versus ultrasound and transcutaneous electrical stimulation; splint versus flax seed oil topical gel; splint versus phonophoresis; splint versus phonophoresis with corticosteroid; splint versus phonophoresis with NSAID. </p> </li> </ol> </p> </section> </section> <section id="CD010003-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <p>For details of risk of bias in the included studies, see the '<a href="./references#CD010003-sec-0212" title="">Characteristics of included studies</a>' tables and <a href="#CD010003-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD010003-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD010003-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD010003-sec-0060"> <h4 class="title">Allocation</h4> <p>Eleven studies reported a method of random sequence generation that we deemed adequate, and we rated them as at low risk of bias (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). In four studies (<a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>), the method of sequence generation was a type of alternation (i.e. non‐random), so we rated these studies at high risk of bias. Fourteen studies did not report enough information regarding the method of random sequence generation, therefore, we rated the risk of bias for this domain as unclear (<a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>). </p> <p>Nine studies described an adequate type of allocation concealment (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>). In four studies (<a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>), the method of allocation was a type of alternation (i.e. non‐random), and therefore allocation was not concealed (high risk). Sixteen studies did not report enough information regarding the method of allocation concealment. Therefore, we rated the risk of bias for this domain as unclear (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>). </p> </section> <section id="CD010003-sec-0061"> <h4 class="title">Blinding</h4> <p>All participants were aware of the allocation. Although 12 studies reported blinding of assessors or clinicians (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>), we rated blinding of participants (performance bias) at high risk of bias in all 29 studies because all outcomes considered for this review were either self‐reported or could be influenced by the participant knowing the allocation. Participants must have known which group they belonged to from the differences between splinting and control interventions, and no study reported using a placebo splint. </p> </section> <section id="CD010003-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>We rated outcome data collected at three months or less at low risk of bias in 20 studies (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>). In these 20 studies there was either a) no missing data or b) the amount of and reasons for missing data were similar across groups. </p> <p>In four studies, we rated attrition bias as unclear because the trial authors reported insufficient information on dropouts or reasons for missing data (<a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>). In five studies, we rated attrition bias as high because of either a) high or imbalanced loss to follow‐up (<a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>) or b) change of study protocol (in <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a> a control group was formed from the participants who did not adhere to the study protocol). </p> <p>We rated six studies reporting outcome data at the long term at low risk of bias (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>) because there were either a) no missing data or b) the amount and reasons for missing data were similar across groups. We rated one trial as being at unclear risk because the reporting of information on dropouts or reasons for missing data was insufficient (<a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>). We rated one study as being at high risk of bias because of large attrition, which varied between reported outcomes (<a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>). </p> </section> <section id="CD010003-sec-0063"> <h4 class="title">Selective reporting</h4> <p>In 19 studies, we rated the risk of bias from selective reporting as unclear, because, while all the outcomes specified in the 'Methods' section of the trial publication were reported, no study had a published protocol or trial registry entry, or studies did not report some outcomes as predefined (it was unclear in these instances if such reporting was because of the nature of findings) (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>; <a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>; <a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>). In nine studies, we rated the risk of selective reporting as being at low risk of bias, because all the outcomes specified were reported and the study protocol or registry record was available (<a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>; <a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>). In one study, we rated the risk of selective reporting as being at high risk of bias, due to partial reporting of prespecified outcomes (<a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). </p> </section> <section id="CD010003-sec-0064"> <h4 class="title">Other potential sources of bias</h4> <p>We judged three studies as being at high risk of other potential sources of bias because of either a potential conflict of interest or unit of analysis issues (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). </p> </section> </section> <section id="CD010003-sec-0065"> <h3 class="title" id="CD010003-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD010003-tbl-0001"><b>Summary of findings 1</b> SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome</a> </p> <section id="CD010003-sec-0066"> <h4 class="title">1. Splint versus no active treatment</h4> <p>Eight studies compared splinting with no active treatment (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>). Four of the studies instructed the participants to wear the splints only at night‐time (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>), while three studies prescribed full‐time splinting (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>). One study did not report sufficient information to be included in the meta‐analysis (<a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>).   </p> <section id="CD010003-sec-0067"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>For short‐term follow‐up, we found low‐certainty evidence (downgraded once for risk of bias and once for inconsistency) from six studies indicating that splinting may not improve CTS symptoms compared with no active treatment (measured with the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, minimal clinically important difference (MCID) value = 1 point). The heterogeneity may be explained by the risk of selection bias; studies at high risk found an effect, while studies at low risk did not. The mean symptom severity score was 2.37 with no active treatment and 0.37 points better with splint (95% confidence interval (CI) 0.82 better to 0.08 worse; 6 studies, 306 participants, I<sup>2</sup> = 93%; <a href="./references#CD010003-fig-0003" title="">Analysis 1.1</a>; <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>). <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a> and <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a> reported data at four weeks; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a> reported data at eight weeks; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a> and <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a> reported data at three months; and <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a> reported data at 25 days, two months and three months, from which we used the three‐month data.  </p> <p>For long‐term follow‐up, we downgraded the certainty of evidence to very low (once for risk of bias, once for inconsistency, and once for imprecision as the 95% CI overlapped with the MCID value). Thus, we are uncertain about the effect of splinting after three months. The mean symptom severity score was 2.48 with no active treatment and 0.64 points better with the splint (95% CI 1.2 better to 0.08 better, 2 studies, 144 participants, I<sup>2</sup> = 83%; <a href="./references#CD010003-fig-0003" title="">Analysis 1.1</a>; <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>). <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a> reported data at six months, but <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a> at 12 months.  </p> <section id="CD010003-sec-0068"> <h6 class="title">Sensitivity analysis</h6> <p>After removal of studies with an unclear or high risk of selection bias, the effect moved towards splinting having a null effect. At short‐term follow‐up, the mean difference (MD) in the BCTQ symptom severity score between splint and no active treatment group was 0.01 points worse (95% CI 0.20 better to 0.22 worse, 3 studies, 124 participants, I<sup>2</sup> = 1%). At long‐term follow‐up, there were no studies with a low risk of selection bias.  </p> <p>We could not study the effect of blinding in a sensitivity analysis because we did not identify any studies that had blinded the participants. </p> </section> </section> <section id="CD010003-sec-0069"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0070"> <h6 class="title">1) Function</h6> <p>For short‐term follow‐up, we found moderate‐certainty evidence (downgraded once for risk of bias) from six trials that splinting probably does not provide a clinically meaningful improvement in hand function (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) compared with no active treatment. The mean functional status score was 1.97 with no active treatment and 0.24 points better with splint (95% CI 0.44 better to 0.03 better, 6 studies, 306 participants, I<sup>2</sup> = 66%; <a href="./references#CD010003-fig-0004" title="">Analysis 1.2</a>; <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>). <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a> and <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a> recorded data at four weeks; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a> recorded data at eight weeks; <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>, <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a> and <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a> recorded data at three months.  </p> <p>At long‐term follow‐up, we graded the certainty of evidence as low (downgraded once for risk of bias and once for imprecision as only 1 study with a low number of participants, n = 34, contributed to the analysis and the 95% CIs touched the MCID value). The mean functional status score was 1.77 with no active treatment and 0.25 points better with the splint (95% CI 0.68 better to 0.18 worse, 1 study, 34 participants; <a href="./references#CD010003-fig-0004" title="">Analysis 1.2</a>; <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD010003-sec-0071"> <h6 class="title">2) Overall improvement</h6> <p>One study reported overall improvement (measured by the Global Impression Change Questionnaire, rated in four categories from 'moderate' or 'much' improvement to 'worsening') at short‐term follow‐up (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>). Since the other studies did not measure this outcome, we could not assess the inconsistency. <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a> also measured the BCTQ scores and was one of the studies reporting the benefit of splinting in the BCTQ Symptom Severity Scale analysis that had high heterogeneity (<a href="./references#CD010003-fig-0003" title="">Analysis 1.1</a>). </p> <p>We rated the evidence for overall improvement as low certainty (downgraded once for risk of bias and once for imprecision, because only one study with 80 participants contributed to the analysis). The evidence indicates that night‐time splinting may result in higher rates of overall improvement compared with no active treatment. In the splinting group, 40 of 40 participants (100%) improved versus 10 of 40 participants (25%) in the no active treatment group, corresponding to a risk ratio (RR) of 3.86 (95% CI 2.29 to 6.51, 1 study, 80 participants) (<a href="./references#CD010003-fig-0005" title="">Analysis 1.3</a>; <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>). This equates to a number needed to treat for an additional beneficial outcome (NNTB) of 2 (95% CI 2 to 2). </p> <p>This outcome was not reported at long‐term follow‐up.</p> </section> <section id="CD010003-sec-0072"> <h6 class="title">3) Health‐related quality of life </h6> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD010003-sec-0073"> <h6 class="title">4) Adverse effects</h6> <p>Two studies reported this outcome (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>). Participants who were prescribed a splint reported higher rate of adverse effects (difficulty in falling asleep, n = 3, and transient paraesthesias after removal of the splint, n = 4); however, the 95% CI overlap suggested that there could be no difference between groups. The certainty of evidence was downgraded to low (once for risk of bias and once for imprecision due to low number of events and overlapping 95% CIs suggesting there could be no effect). </p> <p><a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a> reported no serious adverse effects in either group and that "some minor adverse outcomes of splint treatment including itching and feelings of discomfort were reported" but did not report the exact numbers. Thus, this trial did not contribute to analyses.  </p> <p>In <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>, adverse effects were reported by seven of 40 participants (17.5%) in the splinting group and by 0 of 40 participants (0%) in the no active treatment group corresponding to an RR of 15.0 (95% CI 0.89 to 254.13, 1 study, 80 participants) (<a href="./references#CD010003-fig-0006" title="">Analysis 1.4</a>; <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>).  </p> </section> <section id="CD010003-sec-0074"> <h6 class="title">5) Referral for surgery</h6> <p>Three studies reported this outcome (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>). We downgraded the certainty of evidence to very low (once for risk of bias, and twice for very serious imprecision, as 95% CIs include substantial effect in both directions). In the splinting group, 4 of 129 participants (3%) were referred to surgery compared to 9 of 114 participants (8%) in the no active treatment group, corresponding to an RR of 0.47 (95% CI 0.14 to 1.58, 3 studies, 243 participants, I<sup>2</sup> = 0%) (<a href="./references#CD010003-fig-0007" title="">Analysis 1.5</a>; <a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>). <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a> reported that 19 of 30 participants (63%) had decided not to pursue surgical intervention after the CTS conservative treatment programme (which implies that 11 of 30 (37%) participants had opted for surgery). However, the outcome was not reported for the control group. </p> </section> </section> </section> <section id="CD010003-sec-0075"> <h4 class="title">2. Splint versus corticosteroid injection</h4> <p>Eight studies were included in this comparison (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>; <a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>), of which one study did not report sufficient data to be included in the meta‐analysis (<a href="./references#CD010003-bbs2-0029" title="IRCT2012110210799N3. Efficacy of steroid injection and wrist splint in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110210799N3 (first received 12 Feb 2013). YazdanpanahP , ArameshST , MalekzadehJM , RahimipourSH . Comparison efficacy of triamcinolone and wrist splint in severe carpal tunnel syndrome in pregnancy. Gynecology &amp; Obstetrics2012;2(5):134. ">Yazdanpanah 2012</a>).   </p> <section id="CD010003-sec-0076"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Moderate‐certainty evidence (downgraded once for risk of bias) indicated that corticosteroids may provide a small but clinically unimportant benefit compared with splinting at short‐term follow‐up. Although the MD favoured corticosteroid injection, the 95% CIs excluded clinically meaningful benefit for injection. The mean symptom severity score (measured by the BCTQ, scale from 1 to 5, higher is worse, MCID value = 1 point) was 1.88 with corticosteroids and 0.28 points worse (95% CI 0.04 worse to 0.51 worse; 5 studies, 459 participants, I<sup>2</sup> = 63%) with splints (<a href="./references#CD010003-fig-0008" title="">Analysis 2.1</a> shows standardised mean difference (SMD) due to various measures at long term). </p> <p>At long‐term follow‐up, the certainty of evidence was downgraded to low (due to the risk of bias and unexplained inconsistency), indicating that there may not be clinically important benefit between splint and corticosteroid injection. The SMD was 0.09 (95% CI ‐0.66 to 0.83, 3 studies, 437 participants, I<sup>2</sup> = 93%) (<a href="./references#CD010003-fig-0008" title="">Analysis 2.1</a>). This translates to 0.06 points worse (95% CI 0.42 better to 0.52 worse) symptom severity score in the BCTQ Symptom Severity Scale with splinting compared with corticosteroid injection (using standard deviation (SD) of 0.63 at baseline from <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>).  </p> </section> <section id="CD010003-sec-0077"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0078"> <h6 class="title">1) Function</h6> <p>Moderate‐certainty evidence (downgraded once for risk of bias) indicates that splinting probably provides little or no benefits compared with corticosteroid injection at short‐term follow‐up. The mean functional status score measured by the BCTQ Functional Status Scale (scale from 1 to 5, higher is worse, MCID value = 0.7 points) was 1.76 for those who received a corticosteroid injection, and 0.16 points worse (95% CI 0.04 better to 0.36 worse, 5 studies, 459 participants, I<sup>2</sup> = 44%) for those who were prescribed a splint (<a href="./references#CD010003-fig-0009" title="">Analysis 2.2</a>). </p> <p>At long‐term follow‐up, the evidence was downgraded to very low (once for risk of bias, once for unexplained inconsistency and once for imprecision as the 95% CI overlapped with the MCID value). The mean functional status score was 1.91 for corticosteroid injection, and 0.33 points worse (95% CI 0.40 better to 1.06 worse, 2 studies, 329 participants, I<sup>2</sup> = 89%) for those who were prescribed a splint (<a href="./references#CD010003-fig-0009" title="">Analysis 2.2</a>). </p> </section> <section id="CD010003-sec-0079"> <h6 class="title">2) Overall improvement</h6> <p><a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a> measured remission of nocturnal paraesthesias, and we used these data. Moderate‐certainty evidence (downgraded once for risk of bias) indicates that corticosteroid injection probably results in a higher rate of remission from nocturnal paraesthesias both at short‐term and long‐term follow‐up. </p> <p>At short‐term follow‐up, 19 of 47 participants (40%) in the splinting group and 37 of 52 participants (71%) in the corticosteroid group had improved, corresponding to an RR of 0.57 (95% CI 0.39 to 0.84, 1 study, 99 participants; <a href="./references#CD010003-fig-0010" title="">Analysis 2.3</a>).  </p> <p>At long‐term follow‐up, 13 of 45 participants (29%) in the splinting group and 40 of 50 participants (80%) in the corticosteroid group had improved, corresponding to an RR of 0.36 (95% CI 0.22 to 0.58, 1 study, 95 participants; <a href="./references#CD010003-fig-0010" title="">Analysis 2.3</a>). </p> <p><a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a> reported median satisfaction score (0 to 5, higher is better). Median satisfaction was 3 (range 1‐5) in the splinting group and 5 in the corticosteroid injection group. </p> </section> <section id="CD010003-sec-0080"> <h6 class="title">3) Health‐related quality of life</h6> <p><a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a> measured this outcome by EQ‐5D‐5L (scale from 0 to 1, higher is better) and <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a> by Health Assessment Questionnaire (scale from 0 to 3, higher is worse). For short‐term follow‐up, we rated the certainty of evidence as low (downgraded once for risk of bias and once for imprecision as the 95% CIs overlapped with the MCID value of 0.074 points). The SMD was ‐0.25 (95% CI ‐0.77 to 0.27, 2 studies, 270 participants, I<sup>2</sup> = 57%) favouring corticosteroid. This translates to 0.05 points worse in EQ‐5D‐5L (95% CI 0.15 worse to 0.05 better, MCID 0.074 points) for those prescribed a splint compared with corticosteroid injection (using an SD of 0.2 from <a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>) (<a href="./references#CD010003-fig-0011" title="">Analysis 2.4</a>). </p> <p>At the long term, moderate‐certainty evidence (downgraded once due to risk of bias) indicates that splinting probably does not improve health‐related quality of life compared with corticosteroid injection. The mean EQ‐5D‐5L score was 0.82 in the corticosteroid group and 0.01 points better (95% CI 0.04 worse to 0.05 better, 1 study, 234 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0011" title="">Analysis 2.4</a> shows SMD due to several measures at the short term). </p> </section> <section id="CD010003-sec-0081"> <h6 class="title">4) Adverse effects</h6> <p>Six studies reported adverse effects (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>; <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a>; <a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>; <a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>). Reported adverse effects in the corticosteroid injection group were: skin changes (n = 4), hot flushes (n = 17), and short‐lasting or long‐lasting (over 3 days) pain (n = 53) (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>), vasovagal syncope (n = 1) (<a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a>), short‐lasting pain (n = 2) or small haematoma (n = 1) (<a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>), short‐lasting pain after the injection (n = 3) (<a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>), and increase in blood glucose level that required increasing the dose of oral antidiabetic drugs (n = 1) (<a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a>). Adverse effects reported in the splinting group were discomfort (n = 11) (<a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a>; <a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a>) and allergic reaction on the skin (n = 1) (<a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a>).  </p> <p>We downgraded the evidence to very low (once for risk of bias, once for imprecision, and once for inconsistency).  </p> <p> <ul id="CD010003-list-0018"> <li> <p><a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a> reported 74 of 116 participants (64%) having adverse effects in the corticosteroid injection group versus 7 of 118 participants (6%) having adverse effects in the splinting group. </p> </li> <li> <p><a href="./references#CD010003-bbs2-0004" title="De EntrambasaguasM , MañezI , GironaG , Lopez-SantoveñaF , PoyatosYJ . Steroid injection, wrist splinting and phonophoresis in carpal tunnel syndrome [Infiltracion de esteroides, ferula de muneca fonoforesis en el syndrome del tunel carpiano]. Rehabilitacion2006;40(4):193-200. ">De Entrambasaguas 2006</a> reported 1 of 24 participants (4%) having adverse effects in the corticosteroid injection group versus 0 of 26 participants (0%) having adverse effects in the splinting group. </p> </li> <li> <p><a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a> reported zero adverse effects in both groups. </p> </li> <li> <p><a href="./references#CD010003-bbs2-0020" title="SevimS , DoguO , CamdevirenH , KaleagasiH , AralM , ArslanE , et al. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurological Sciences2004;25(2):48-52. [PMID: 15221621]">Sevim 2004</a> reported 3 of 60 participants (5%) having adverse effects in the corticosteroid injection group versus 1 of 60 participants (2%) having adverse effects in the splinting group. </p> </li> <li> <p><a href="./references#CD010003-bbs2-0021" title="NCT02140632. Efficacy study of local steroid injection and wrist splinting for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02140632 (first received 16 May 2014). SoH , ChungV , ChengJ , YipML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. Annals of the Rheumatic Diseases2017;76(Suppl 2):998–9. SoH , ChungV . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial and a qualitative exploration. Annals of the Rheumatic Diseases2015;74:1218. SoH , ChungVCH , ChengJCK , YipRML . Local steroid injection versus wrist splinting for carpal tunnel syndrome: a randomized clinical trial. International Journal of Rheumatic Diseases2018;21(1):102–7. ">So 2018</a> reported 3 of 25 participants (12%) having adverse effects in the corticosteroid injection group versus 4 of 25 participants (16%) having adverse effects in the splinting group. </p> </li> <li> <p><a href="./references#CD010003-bbs2-0022" title="Taşpınar Ş, ŞahinF , ErçalıkC , KuranB , BarkutK , ÇelikM , et al. Comparison of the efficacy of corticosteroid injection, night splint, and physiotherapy in diabetic carpal tunnel syndrome [Diyabetik karpal tünel sendromunda kortikosteroid enjeksiyonu, gece ateli ve fizik tedavinin etkinliğinin karşılaştırılması]. Turkish Journal of Physical Medicine and Rehabilitation2007;53(2):54-60. ">Taspinar 2007</a> reported 1 of 18 participants (5.5%) having adverse effects in the corticosteroid injection group versus 0 of 18 participants (0%) having adverse effects in the splinting group. </p> </li> </ul> </p> <p>The pooled RR was 0.32 (95% CI 0.08 to 1.26, 6 studies, 590 participants, I² = 67%) (<a href="./references#CD010003-fig-0012" title="">Analysis 2.5</a>). </p> </section> <section id="CD010003-sec-0082"> <h6 class="title">5) Referral for surgery</h6> <p><a href="./references#CD010003-bbs2-0003" title="BurtonCL , Rathod-MistryT , Blagojevic-BucknallM , ChestertonLS , DavenportG , DziedzicKS , et al. P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology2020;59(Suppl_2):111.138. ChestertonLS , Blagojevic-BucknallM , BurtonC , DziedzicKS , DavenportG , JowettSM , et al. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet2018;392(10156):1423-33. ChestertonLS , DziedzicKS , Van der WindtDA , DavenportG , MyersHL , RathodT , et al. The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol. BMC Musculoskeletal Disorders2016;17(1):1-11. EUCTR2013-001435-48-GB. Injections versus splints in carpal tunnel syndrome. clinicaltrialsregister.eu/ctr-search/trial/2013-001435-48/results (first received 3 June 2013). ISRCTN09392969. The clinical and cost effectiveness of a steroid injection versus a night splint for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN09392969 (first received 1 May 2014). NCT02038452. Injection versus splinting in carpal tunnel syndrome. clinicaltrials.gov/show/NCT02038452 (first received 16 Jan 2014). ">Chesterton 2018</a> reported this outcome at six weeks and at six months follow‐up (in the analysis we included only the results from the 6 months follow‐up) and <a href="./references#CD010003-bbs2-0005" title="De MoraesVY , QueirozJ , Raduan-NetoJ , FernandesM , OkamuraA , BellotiJC . Nonsurgical treatment for symptomatic carpal tunnel syndrome: a randomized clinical trial comparing local corticosteroid injection versus night orthosis. Journal of Hand Surgery2021;46(4):P295-300.e1. [CLINICALTRIALS: NCT03196817]NCT03196817. Non-surgical treatment of carpal tunnel syndrome: night splint versus local corticosteroid infiltration. clinicaltrials.gov/show/NCT03196817 (first received 23 June 2017). ">De Moraes 2021</a> reported at six months.  </p> <p>The certainty of evidence was rated as very low (downgraded once for risk of bias and twice for serious imprecision). At six months, 15 of 166 participants (9%) in the splinting group were referred to surgery compared to 25 of 168 (15%) in the corticosteroid group, corresponding to an RR of 0.60 (95% CI 0.33 to 1.09, 2 studies, 334 participants, I² = 0%) (<a href="./references#CD010003-fig-0013" title="">Analysis 2.6</a>). </p> </section> </section> </section> <section id="CD010003-sec-0083"> <h4 class="title">3. Splint versus oral steroid</h4> <p>One study (<a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a>) with 76 participants provided data for this comparison at one month and three months follow‐up. We used the data from three months follow‐up for short‐term analysis. One study (<a href="./references#CD010003-bbs2-0012" title="MadjdinasabN , ZadehNS , AssarzadeganF , AliAM , PipelzadehM . Efficacy comparison of splint and oral steroid therapy in nerve conduction velocity and latency median nerve in carpal tunnel syndrome. Pakistan Journal of Medical Sciences2008;24(5):725-8. [EMBASE: 2008533657]">Madjdinasab 2008</a>) reported only electrophysiological outcomes and thus was not included in the meta‐analysis.   </p> <section id="CD010003-sec-0084"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>For short‐term follow‐up, low‐certainty evidence (downgraded once for risk of bias and once for imprecision, as only one study with a low number of randomised participants, n = 76, contributed to the analysis) suggests that splinting and oral steroid may provide comparable benefits for improving symptoms. At short‐term follow‐up, the mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 2.18 for those prescribed an oral steroid and 0.25 points worse (95% CI 0.03 better to 0.53 worse, 1 study, 71 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0014" title="">Analysis 3.1</a>). </p> <p>The only study in this comparison did not report this outcome at the long term. </p> </section> <section id="CD010003-sec-0085"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0086"> <h6 class="title">1) Function</h6> <p>For short‐term follow‐up, low‐certainty evidence (downgraded once for risk of bias and once for imprecision, as only 1 study with a low number of randomised participants, n = 76, contributed to the analysis) indicated that hand function (measured by the BCTQ Functional Status Scale from 1 to 5, higher is worse, MCID = 0.7 points) may not differ between splinting and oral steroid use. The mean functional status score was 1.45 for those prescribed an oral steroid and 0.12 points worse (95% CI 0.06 better to 0.3 worse, 1 study, 71 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0015" title="">Analysis 3.2</a>). </p> <p>The only study in this comparison did not report this outcome at the long term. </p> </section> <section id="CD010003-sec-0087"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0088"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0089"> <h6 class="title">4) Adverse effects</h6> <p><a href="./references#CD010003-bbs2-0014" title="MishraS , PrabhakarS , LalV , ModiM , DasCP , KhuranaD . Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study. Neurology India2006;54(3):286-90. ">Mishra 2006</a> reported 2 of 36 participants (6%) having adverse effects in the splinting group (discomfort and swelling of the hand) and 0 of 35 participants (0%) having adverse effects in the oral steroid group. This corresponds to an RR of 4.86 (95% CI 0.24 to 97.86, 1 study, 71 participants). The evidence was downgraded to very low (once for risk of bias and twice for very serious imprecision) indicating that we are uncertain about the risk for adverse effects between these two treatments (<a href="./references#CD010003-fig-0016" title="">Analysis 3.3</a>). </p> </section> <section id="CD010003-sec-0090"> <h6 class="title">5) Referral for surgery</h6> <p>The only study in this comparison did not report this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0091"> <h4 class="title">4. Splint plus corticosteroid injection versus corticosteroid injection</h4> <p>One study with 52 participants provided data for this comparison at six weeks and 12 weeks follow‐up (<a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>). We used the data from 12 weeks follow‐up for short‐term analysis. </p> <section id="CD010003-sec-0092"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>For short‐term follow‐up, we graded the evidence as being of low certainty (downgraded once for risk of bias and once for imprecision, as only one study with a low number of participants, n = 52, contributed to the analysis). This evidence indicates that splinting given together with corticosteroid injection may not provide benefits in symptoms compared with corticosteroid injection alone. The mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 1.49 with corticosteroid injection alone and 0.17 points better (95% CI 0.43 better to 0.09 worse, 1 study, 52 participants) with corticosteroid injection plus splint (<a href="./references#CD010003-fig-0017" title="">Analysis 4.1</a>). </p> <p>The only study in this comparison did not report this outcome at the long term.</p> </section> <section id="CD010003-sec-0093"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0094"> <h6 class="title">1) Function</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only one study with a low number of participants, n = 52, contributed to the analysis) indicated that splinting given together with corticosteroid injection may not provide benefits in function compared with corticosteroid injection alone at short‐term follow‐up. The mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.32 with corticosteroid alone and 0.05 points better (95% CI 0.28 better to 0.18 worse, 1 study, 52 participants) with corticosteroid injection plus splint (<a href="./references#CD010003-fig-0018" title="">Analysis 4.2</a>). </p> <p>The only study in this comparison did not report this outcome at the long term.</p> </section> <section id="CD010003-sec-0095"> <h6 class="title">2) Overall improvement</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision) indicated that splinting given together with corticosteroid injection may not result in higher rates of overall improvement compared with corticosteroid alone at short‐term follow‐up. In the splint plus corticosteroid injection group, 20 of 26 participants (77%) reported 'complete recovery' or 'much improved' (measured by a 6‐point Likert‐type scale) compared with 15 of 26 participants (58%) in the corticosteroid injection group alone. This corresponds to an RR of 1.33 (95% CI 0.90 to 1.97, 1 study, 52 participants) (<a href="./references#CD010003-fig-0019" title="">Analysis 4.3</a>).  </p> <p>The only study in this comparison did not report this outcome at the long term.</p> </section> <section id="CD010003-sec-0096"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0097"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0098"> <h6 class="title">5) Referral for surgery</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0099"> <h4 class="title">5. Splint versus exercise</h4> <p>One study (<a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a>) with 20 participants compared splinting with nerve and tendon gliding exercises at one week.  </p> <section id="CD010003-sec-0100"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only one study with a low number of participants, n = 20, contributed to the analysis) indicates that the effect of splinting and nerve and tendon gliding exercises may not differ at short‐term follow‐up. The mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 1.73 with exercises and 0.12 points worse (95% CI 0.38 better to 0.62 worse, 1 study, 20 participants) with splinting (<a href="./references#CD010003-fig-0020" title="">Analysis 5.1</a>). </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0101"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0102"> <h6 class="title">1) Function</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only 1 study with a low number of participants, n = 20, contributed to the analysis) indicates that function may not differ at the short term regardless of whether you are prescribed a splint or nerve and tendon gliding exercises. The mean functional status score (measured by the BCTQ Functional Status Score from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.15 for those who were prescribed nerve and tendon gliding exercises, but was 0.30 points worse (95% CI 0.11 better to 0.71 worse, 1 study, 20 participants) for those who were prescribed a splint (<a href="./references#CD010003-fig-0021" title="">Analysis 5.2</a>). </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0103"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0104"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0105"> <h6 class="title">4) Adverse effects</h6> <p><a href="./references#CD010003-bbs2-0019" title="ACTRN12611000690954. The effect of splinting and exercises on swelling of the nerve in patients with carpal tunnel syndrome. anzctr.org.au/ACTRN12611000690954.aspx (first received 7 July 2011). SchmidAB , ElliottJM , StrudwickMW , LittleM , CoppietersMW . Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome - an MRI study to reveal therapeutic mechanisms. Journal of Orthopaedic Research2012;30(8):1343-50. ">Schmid 2012</a> reported 0 of 10 participants (0%) having adverse effects in the splinting group and 0 of 10 participants (0%) having adverse effects in the nerve and tendon gliding exercise group. Thus, we could not estimate the risk (very low‐certainty evidence). </p> </section> <section id="CD010003-sec-0106"> <h6 class="title">5) Referral for surgery</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0107"> <h4 class="title">6. Stretching splint versus stretching exercises</h4> <p>One study with 50 participants compared Dynasplint (providing a low load transversal ligament stretching) with stretching exercises (<a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). </p> <section id="CD010003-sec-0108"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p><a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a> reported symptom severity scores using an atypical scoring version of the BCTQ Symptom Severity Scale at short‐term follow‐up. According to the paper, the stretching splint (Dynasplint) group participants improved from 45.5 to 32.4 (P &lt; 0.001) points, and in the stretching exercises group, the symptoms increased from 44.3 to 46.0 at two months. </p> <p>The only study in this comparison did not measure symptoms at the long term.</p> </section> <section id="CD010003-sec-0109"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0110"> <h6 class="title">1) Function</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0111"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0112"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0113"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0114"> <h6 class="title">5) Referral for surgery</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision due to a low number of events) indicated that a stretching splint may decrease referral to surgery at one year. <a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a> reported that 7 of 25 participants (28%) had surgery in the stretching splint group and 16 of 25 participants (64%) in the stretching exercises group, corresponding to an RR of 0.44 (95% CI 0.22 to 0.88, 1 study, 50 participants) (<a href="./references#CD010003-fig-0022" title="">Analysis 6.1</a>). </p> </section> </section> </section> <section id="CD010003-sec-0115"> <h4 class="title">7. Splint versus kinesiology taping</h4> <section id="CD010003-sec-0116"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Four studies) provided data for this outcome (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>). <a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a> reported data at six weeks; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a> reported data at four weeks; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a> reported data at three weeks; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a> reported data at 25 days, two months and three months, from which we used the data from 25 days as it was the closest time point to the other studies in this comparison. </p> <p>For short‐term follow‐up, low‐certainty evidence (downgraded once for risk of bias, once for inconsistency and once for imprecision as the 95% CI overlapped with the MCID value) indicated that splinting may not improve symptoms compared with kinesiology taping. The 95% CI did not exclude a clinically important benefit for kinesiology taping up to three months after starting treatment. The mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 2.05 with kinesiology taping and 0.49 points worse (95% CI 0.05 better to 1.03 points worse, 4 studies, 168 participants, I<sup>2</sup> = 78%) with a splint (<a href="./references#CD010003-fig-0023" title="">Analysis 7.1</a>). </p> <p>None of the studies in this comparison reported this outcome at the long term.</p> </section> <section id="CD010003-sec-0117"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0118"> <h6 class="title">1) Function</h6> <p>Four studies (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>) provided data for this outcome. <a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a> reported data at six weeks; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a> reported data at four weeks; <a href="./references#CD010003-bbs2-0011" title="KocaogluS , EsmerA , OkumusM , OzturkE , KaygisizF , DemirG . The kinesio taping, local anesthetic/steroid injection and splinting in the treatment of patients with carpal tunnel syndrome: a clinical and electrophysiological study. Osteoporosis International2017;28(Suppl 1):S447. ">Kocaoglu 2017</a> reported data at three weeks; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a> reported data at three months. </p> <p>Low‐certainty evidence (downgraded once for risk of bias, once for inconsistency and once for imprecision as the 95% CI overlapped with the MCID value) indicated that splinting and kinesiology taping may have comparable effects on hand function at short‐term follow‐up. The 95% CI did not exclude clinically important benefit for kinesiology taping. The mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.72 for those prescribed kinesiology tape and 0.11 points worse (95% CI 0.54 better to 0.75 worse, 4 studies, 168 participants, I<sup>2</sup> = 79%) for those prescribed a splint (<a href="./references#CD010003-fig-0024" title="">Analysis 7.2</a>). </p> <p>None of the studies in this comparison reported this outcome at the long term.</p> </section> <section id="CD010003-sec-0119"> <h6 class="title">2) Overall improvement</h6> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD010003-sec-0120"> <h6 class="title">3) Health‐related quality of life</h6> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD010003-sec-0121"> <h6 class="title">4) Adverse effects</h6> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD010003-sec-0122"> <h6 class="title">5) Referral for surgery</h6> <p>None of the studies in this comparison reported this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0123"> <h4 class="title">8. Splint versus rigid tape</h4> <p>One study (<a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>) with 30 participants provided data for this comparison at three weeks.  </p> <section id="CD010003-sec-0124"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>For short‐term follow‐up, low‐certainty evidence (downgraded once for risk of bias and once for imprecision) suggests that rigid taping may slightly improve symptoms compared to night‐time splinting but the 95% CI are consistent with both clinically important and unimportant benefit. The mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 1.48 with rigid tape and 1.05 points worse (95% CI 0.58 worse to 1.52 worse, 1 study, 30 participants) with a splint (<a href="./references#CD010003-fig-0025" title="">Analysis 8.1</a>). </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0125"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0126"> <h6 class="title">1) Function</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision) suggests that hand function may be better after rigid taping compared with splinting at short‐term follow‐up. The 95% CIs excluded benefit for splinting. The mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.71 for those prescribed rigid taping and 0.87 points worse (95% CI 0.48 worse to 1.26 worse, 1 study, 30 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0026" title="">Analysis 8.2</a>). </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0127"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0128"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0129"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0130"> <h6 class="title">5) Referral for surgery</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0131"> <h4 class="title">9. Splint versus platelet‐rich plasma (PRP)</h4> <p>One study (<a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a>) with 60 participants provided data for this comparison at one, three, and six months follow‐up. We used the data from three months follow‐up for short‐term analysis. </p> <section id="CD010003-sec-0132"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only one study with a low number of participants, n = 60, contributed to the analysis) suggests the symptom improvement between splinting and PRP may be clinically unimportant both at the short term and long term.  </p> <p>At short‐term follow‐up, the mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 1.43 for those who received PRP and 0.21 points worse (95% CI 0.01 worse to 0.41 worse, 1 study, 60 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0027" title="">Analysis 9.1</a>). </p> <p>At long‐term follow‐up, the mean symptom severity score was 1.29 for those who received PRP and 0.18 points worse (95% CI 0.01 worse to 0.35 worse, 1 study, 60 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0027" title="">Analysis 9.1</a>). </p> </section> <section id="CD010003-sec-0133"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0134"> <h6 class="title">1) Function</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only one study with a low number of participants, n = 60, contributed to the analysis) suggests the difference between splinting and PRP is probably clinically unimportant in function both at the short term and long term. </p> <p>At short‐term follow‐up, the mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.35 with PRP and 0.35 points worse (95% CI 0.16 worse to 0.54 worse, 1 study, 60 participants) with a splint (<a href="./references#CD010003-fig-0028" title="">Analysis 9.2</a>).  </p> <p>At long‐term follow‐up, the mean functional status score was 1.30 with PRP and 0.32 points worse (95% CI 0.12 worse to 0.52 worse, 1 study, 60 participants) with a splint (<a href="./references#CD010003-fig-0028" title="">Analysis 9.2</a>). </p> </section> <section id="CD010003-sec-0135"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0136"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0137"> <h6 class="title">4) Adverse effects</h6> <p><a href="./references#CD010003-bbs2-0028" title="NCT02539186. The effect of platelet rich plasma for carpal tunnel syndrome. clinicaltrials.gov/show/NCT02539186 (first received 2 Sep 2015). WuYT , HoTY , ChouYC , KeMJ , LiTY , HuangGS , et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Scientific Reports2017;7(1):94. ">Wu 2017</a> reported 0 of 30 participants (0%) having adverse effects in the splinting group and 0 of 30 participants (0%) having adverse effects in the PRP group. Thus, we could not estimate the risk (very low‐certainty evidence). </p> </section> <section id="CD010003-sec-0138"> <h6 class="title">5) Referral for surgery</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0139"> <h4 class="title">10. Splint versus extracorporeal shock wave therapy (ESWT)</h4> <p>One study (<a href="./references#CD010003-bbs2-0023" title="UlucaköyRK , YurdakulFG , BodurH . Extracorporeal shock wave therapy as a conservative treatment option for carpal tunnel syndrome: a double-blind, prospective, randomized, placebo-controlled study. Turkish Journal of Physical Medicine and Rehabilitation2020;66(4):388–97. ">Ulucakoy 2020</a>) with 83 participants provided data for this comparison. Results were measured at one month and three months follow‐up. We used the data from three months follow‐up for short‐term analysis.  </p> <section id="CD010003-sec-0140"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Based upon moderate‐certainty evidence (downgraded once for risk of bias), splinting probably does not improve symptoms compared with ESWT at short‐term follow‐up. The mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 1.8 for those receiving ESWT and 0.1 points better (95% CI 0.40 better to 0.20 worse, 1 study, 83 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0029" title="">Analysis 10.1</a>).  </p> <p>The only study in this comparison did not measure this outcome in the long term.</p> </section> <section id="CD010003-sec-0141"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0142"> <h6 class="title">1) Function</h6> <p>Moderate‐certainty evidence (downgraded once for risk of bias) indicates that splinting probably does not improve function compared with ESWT at short‐term follow‐up. The mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.9 with ESWT and 0.1 points better (95% CI 0.44 better to 0.24 worse, 1 study, 83 participants) for those prescribed a splint (<a href="./references#CD010003-fig-0030" title="">Analysis 10.2</a>).  </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0143"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0144"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0145"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0146"> <h6 class="title">5) Referral for surgery</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0147"> <h4 class="title">11. Dynamic splint plus rehabilitation versus rehabilitation</h4> <p>One study with 24 participants compared a dynamic splint (which allowed a limited range of motion from 15 degrees of flexion to 15 degrees of extension) plus rehabilitation (activity, ergonomic modifications, nerve and tendon gliding exercises, massage, carpal bones and nerve mobilisations, stretches of upper extremity and flexor retinaculum) with rehabilitation alone at six weeks (<a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>). </p> <section id="CD010003-sec-0148"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only one study with a low number of participants, n = 24  contributed to the analysis) indicates that dynamic splinting given together with rehabilitation may not improve symptoms compared with rehabilitation alone at short‐term follow‐up. </p> <p>The mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 2.25 with rehabilitation and 0.01 points worse (95% CI 0.61 better to 0.63 worse, 1 study, 24 participants) with splinting and rehabilitation (<a href="./references#CD010003-fig-0031" title="">Analysis 11.1</a>). </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0149"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0150"> <h6 class="title">1) Function</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only 1 one study with a low number of participants, n = 24, contributed to the analysis) indicates that dynamic splinting given together with rehabilitation may not improve function compared with rehabilitation alone. The mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.9 with rehabilitation and 0.08 points better (95% CI 0.67 better to 0.51 worse, 1 study, 24 participants) with splinting and rehabilitation (<a href="./references#CD010003-fig-0032" title="">Analysis 11.2</a>).  </p> <p>The only study in this comparison did not measure this outcome at long‐term follow‐up.</p> </section> <section id="CD010003-sec-0151"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0152"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0153"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> <section id="CD010003-sec-0154"> <h6 class="title">5) Referral to surgery</h6> <p>The only study in this comparison did not measure this outcome.</p> </section> </section> </section> <section id="CD010003-sec-0155"> <h4 class="title">12. Splint six weeks versus splint 12 weeks</h4> <p>One study with 40 participants compared wearing a neutral wrist splint for six weeks to 12 weeks (<a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a>). The splint was worn at night primarily, but participants could wear the splint during the day (in addition to night‐time) for activities that provoked symptoms.  </p> <section id="CD010003-sec-0156"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only 1 study with a low number of participants, n = 37, contributed to the analysis) indicates that an additional six weeks splinting (6 versus 12 weeks) may not improve symptoms at short‐term follow‐up. At 12 weeks, the mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 2.17 after 12 weeks of splinting and 0.18 points better (95% CI 0.62 better to 0.26 worse) with six weeks of splinting (<a href="./references#CD010003-fig-0033" title="">Analysis 12.1</a>).  </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0157"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0158"> <h6 class="title">1) Function</h6> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only 1 study with a low number of  participants, n = 37, contributed to the analysis) indicates that an additional six weeks of splinting (6 versus 12 weeks) may not improve function beyond that achieved at six weeks total. At 12 weeks post‐commencement of splinting, the BCTQ functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.6 after 12 weeks of splinting and 0.05 points worse (95% CI 0.39 better to 0.49 worse) with six weeks splinting (<a href="./references#CD010003-fig-0034" title="">Analysis 12.2</a>).   </p> <p>The only study in this comparison did not measure this outcome at the long term.</p> </section> <section id="CD010003-sec-0159"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not report this outcome.</p> </section> <section id="CD010003-sec-0160"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not report this outcome.</p> </section> <section id="CD010003-sec-0161"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not report this outcome.</p> </section> <section id="CD010003-sec-0162"> <h6 class="title">5) Referral for surgery</h6> <p><a href="./references#CD010003-bbs2-0007" title="GatheridgeMA , SholtyEA , InmanA , PattilloM , MindrupF , SandersonDL . Splinting in carpal tunnel syndrome: the optimal duration. Military Medicine2020;185(11-12):e2049-54. ">Gatheridge 2020</a> reported this outcome at the long term, over three years. We downgraded the certainty of evidence to very low (once for risk of bias and twice for very serious imprecision as the 95% CIs included substantial effect in both directions). In the short‐term splinting group, 2 of 17 participants (12%) had been referred to surgery compared to 4 of 20 participants (20%) in the long‐term splinting group corresponding to an RR of 0.59 (95% CI 0.12 to 2.83, 1 study, 37 participants; <a href="./references#CD010003-fig-0035" title="">Analysis 12.3</a>). </p> </section> </section> </section> <section id="CD010003-sec-0163"> <h4 class="title">13. Splint six weeks versus splint six months</h4> <p>One study compared night‐time splinting for six weeks with night‐time splinting for six months (<a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>). Both groups also received usual care (non‐steroidal anti‐inflammatory drugs (NSAIDs), (naproxen 500 mg three times a day) for 10 days, vitamin B1 and B6 tabs for 6 weeks, physiotherapy (paraffin bath with controlled temperature, ultrasound underwater and grip exercises)). Outcomes were measured at six weeks and six months, but as both groups received exactly the same intervention for the first six weeks, we did not include the six weeks data in the analysis.  </p> <section id="CD010003-sec-0164"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>At long‐term follow‐up, low‐certainty evidence (downgraded once for risk of bias and once for imprecision as the 95% CI overlapped with the MCID value) indicates that six months of splinting may improve symptoms compared with six weeks of splinting. At six months, the mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 2 with six months splinting and 1.3 points worse (95% CI 0.81 worse to 1.79 worse, 1 study, 156 participants) with six weeks of splinting (<a href="./references#CD010003-fig-0036" title="">Analysis 13.1</a>).  </p> </section> <section id="CD010003-sec-0165"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0166"> <h6 class="title">1) Function</h6> <p>At long‐term follow‐up, moderate‐certainty evidence (downgraded once for risk of bias) indicated that six months of splinting probably improves functional status compared with six weeks of splinting. </p> <p>At six months, the mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 1.8 with six months splinting and 2.3 points worse (95% CI 1.44 worse to 3.16 worse, 1 study, 156 participants) with six weeks of splinting (<a href="./references#CD010003-fig-0037" title="">Analysis 13.2</a>). </p> </section> <section id="CD010003-sec-0167"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0168"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0169"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0170"> <h6 class="title">5) Referral for surgery</h6> <p>In the group that was prescribed a splint for six weeks, 4 of 59 participants (7%) had surgery versus 0 of 59 participants (0%) in the group that wore the splint for six months. This corresponds to an RR of 9.00 (95% CI 0.50 to 163.53, 1 study, 118 participants) (<a href="./references#CD010003-fig-0038" title="">Analysis 13.3</a>). We downgraded the certainty of evidence to very low (once for risk of bias and twice for very serious imprecision as the 95% CI included substantial effects in both directions). </p> </section> </section> </section> <section id="CD010003-sec-0171"> <h4 class="title">14. Night‐time splinting versus full‐time splinting</h4> <p>One quasi‐randomised trial with 24 participants compared night‐time splinting versus full‐time splinting for six weeks, at six weeks follow‐up (<a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>). </p> <section id="CD010003-sec-0172"> <h5 class="title">Primary outcome: CTS symptoms</h5> <p>Low‐certainty evidence (downgraded once for risk of bias and once for imprecision as only 1 study with a low number of participants, n = 26,  contributed to the analysis) indicates that symptoms after six weeks night‐time splinting and full‐time splinting may not differ. </p> <p>The mean symptom severity score (measured by the BCTQ Symptom Severity Scale from 1 to 5 points, higher is worse, MCID value = 1 point) was 2.3 with night‐time splints and 0.21 points better (95% CI 0.83 better to 0.41 worse, 1 study, 24 participants) with full‐time splinting (<a href="./references#CD010003-fig-0039" title="">Analysis 14.1</a>). </p> <p>The only study in this comparison did not report this outcome at the long term. </p> </section> <section id="CD010003-sec-0173"> <h5 class="title">Secondary outcomes</h5> <section id="CD010003-sec-0174"> <h6 class="title">1) Function</h6> <p>Very low‐certainty evidence (downgraded once for risk of bias and twice for imprecision; 1 study with 26 randomised participants and the 95% CI overlapping the MCID) indicates that we are uncertain about the effect on function after six weeks night‐time splinting and full‐time splinting. </p> <p>At six weeks, the mean functional status score (measured by the BCTQ Functional Status Scale from 1 to 5 points, higher is worse, MCID value = 0.7 points) was 2.14 with night‐time splinting and 0.21 points better (95% CI 0.87 better to 0.45 worse, 1 study, 24 participants) with full‐time splinting (<a href="./references#CD010003-fig-0040" title="">Analysis 14.2</a>). </p> <p>The only study in this comparison did not report this outcome at the long term. </p> </section> <section id="CD010003-sec-0175"> <h6 class="title">2) Overall improvement</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0176"> <h6 class="title">3) Health‐related quality of life</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0177"> <h6 class="title">4) Adverse effects</h6> <p>The only study in this comparison did not report this outcome. </p> </section> <section id="CD010003-sec-0178"> <h6 class="title">5) Referral for surgery</h6> <p>The only study in this comparison did not report this outcome.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010003-sec-0179" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010003-sec-0179"></div> <section id="CD010003-sec-0180"> <h3 class="title" id="CD010003-sec-0180">Summary of main results</h3> <p>The objective of this review was to assess the effects (benefits and harms) of splinting for people with carpal tunnel syndrome (CTS). We considered the results of 29 trials in a total of 1937 participants. Eight studies examined our primary comparison of splinting versus no treatment, 20 compared splinting with another non‐surgical intervention (or splinting and a co‐intervention compared to the same co‐intervention). Three studies compared different splinting regimens. Most of the participants were female (81 %). Participants had an average age ranging from 42 to 60 years.  </p> <p>Ten studies measured the effect of splint when delivered with some other non‐surgical intervention: an exercise programme (<a href="./references#CD010003-bbs2-0001" title="AktürkS , BüyükavcıR , Aslan Ö, ErsoyY . Comparison of splinting and Kinesio taping in the treatment of carpal tunnel syndrome: a prospective randomized study. Clinical Rheumatology2018;37(9):2465-9. ">Akturk 2018</a>); a physical therapy programme (consisting of heat‐application‐ultrasound‐TENS) and strengthening exercises (<a href="./references#CD010003-bbs2-0006" title="EraslanL , YuceD , KermalliAM , BaltaciG . Comparison of short-term effects of rigid tape and night splint on pain and function in patient with carpal tunnel syndrome: a randomized clinical trial. Türk Fizyoterapi ve Rebilitasyon Dergisi2014;25(1):8-15. ">Eraslan 2014</a>); usual rehabilitation including activity or ergonomic modifications, nerve‐ and tendon‐gliding exercises, massage, carpal bones and nerve mobilisations, stretches of upper extremity and flexor retinaculum (<a href="./references#CD010003-bbs2-0010" title="IRCT2015061522753N1. Effects of wrist limited dynamic splint on carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061522753N1 (first received 22 Feb 2015). JaladatSM , AbdolvahabM , MoghadamBA , AshrafA , JaliliM , BaghestaniA . The effectiveness of limited dynamic wrist splints on the symptoms, function, and strength of women with carpal tunnel syndrome: a controlled trial study. Journal of Rehabilitation Sciences and Research2017;1(4):1-5. ">Jaladat 2017</a>); tendon and nerve‐gliding exercises (<a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>); corticosteroid injection (<a href="./references#CD010003-bbs2-0025" title="NCT02708693. Efficacy of combined ultrasound guided steroid injection and splinting in patients with carpal tunnel syndrome. clinicaltrials.gov/show/NCT02708693 (first received 15 March 2016). WangJC , LiaoKK , LinKP , ChouCL , YangTF , HuangYF , et al. Efficacy of combined ultrasound-guided steroid injection and splinting in patients with carpal tunnel syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2017;98(5):947-56. ">Wang 2017</a>); nonsteroidal antiinflammatory drugs (NSAIDs), B<sub>1</sub> and B<sub>6</sub>, paraffin bath, ultrasound underwater and grip exercise (<a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>); education (<a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>); and ergonomic education (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>). </p> <section id="CD010003-sec-0181"> <h4 class="title">Splint versus no active treatment</h4> <p>For the primary outcome (symptoms), we found low‐certainty evidence indicating that splinting may provide little or no benefit at short‐term follow‐up compared with no active treatment. The effect estimates excluded clinically relevant benefits, but there is no consensus on the ideal Minimal Clinically Important Difference (MCID) value in this specific context, and the chosen MCID value can affect interpretation (see <a href="#CD010003-sec-0185">Overall completeness and applicability of evidence</a>). Regarding long‐term follow‐up (over 3 months), we are uncertain whether splinting provides benefit for CTS symptoms (<a href="./full#CD010003-tbl-0001">summary of findings Table 1</a>).  </p> <p>Lack of blinding and heterogeneity in the treatment effects across the studies were the main limitations in the studies comparing splinting versus no active treatment at short‐term follow‐up. We explored heterogeneity by removing studies at high or unclear risk of selection bias. This left three small studies (i.e. <a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>) with low heterogeneity and moved the effect towards no effect, suggesting that the benefits observed in <a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a> and <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a> may relate to shortcomings in the randomisation process.  </p> <p>On the other hand, the two studies reporting benefit for splint used splint only at night‐time (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>; <a href="./references#CD010003-bbs2-0016" title="PremoselliS , SioliP , GrossiA , CerriC . Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-month clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Europa Medicophysica2006;42(2):121-6. [PMID: 16767058]">Premoselli 2006</a>), and one study using night‐time splint reported no benefit (<a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>). The other trialists instructed participants to wear splints full time. Thus, inconsistency could also be partially explained by night‐time splinting having a different effect compared with full‐time use. However, one small study comparing night‐time splinting with full‐time splinting did not support this hypothesis (<a href="./references#CD010003-bbs2-0024" title="WalkerWC , MetzlerM , CifuDX , SwartzZ . Neutral wrist splinting in carpal tunnel syndrome: a comparison of night-only versus full-time wear instructions. Archives of Physical Medicine and Rehabilitation2000;81(4):424-9. [PMID: 10768530]">Walker 2000</a>). Thus, it remains unclear if night‐time splinting could improve symptoms, and if those benefits are present only at night‐time or also at daytime, and if they are large enough to be important for people with CTS. </p> <p>For secondary outcomes, moderate‐certainty evidence suggested that splint probably does not improve hand function in the short term and may not improve hand function in the long term. Low‐certainty evidence based upon one study suggested a benefit for splinting (RR of 3.9) in overall improvement (those reporting 'moderately' or 'much improved') (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>). This benefit was found in the study, which also reported benefits for CTS symptoms, unlike most studies. In this study, the first author reported owning the patent for the splint being tested. Therefore, we consider the evidence regarding benefits in overall improvement limited until confirmed in other studies.  </p> <p>None of the studies reported general health‐related quality of life (HRQoL) in the primary comparison and the estimates were very imprecise for referral to surgery. We are thus uncertain about the effect of splinting for these outcomes. </p> <p>Splinting may cause transient adverse effects (difficulty falling asleep and paraesthesia after removal). These adverse effects are generally minor and are not likely to persist after use is discontinued.  </p> </section> <section id="CD010003-sec-0182"> <h4 class="title">Other comparisons</h4> <p>The other comparisons supported the findings from the primary comparison. Splinting may not provide benefits in CTS symptoms or hand function when given together with corticosteroid injection (moderate‐certainty evidence) or with rehabilitation (low‐certainty evidence) nor when compared with corticosteroid (injection or oral; low certainty), exercises (low certainty), kinesiology taping (low certainty), rigid taping (low certainty), and probably does not improve outcomes compared with platelet‐rich plasma (moderate certainty), or extracorporeal shock wave therapy (moderate certainty).  </p> </section> <section id="CD010003-sec-0183"> <h4 class="title">Splinting versus corticosteroid injection</h4> <p>Corticosteroid injections (when compared to splinting) appeared to provide a small, but clinically unimportant benefit in the short term with respect to symptom resolution (but not in improving function). However, this effect vanished at long‐term follow‐up, which is consistent with findings that the effect of corticosteroid injection is likely transient (<a href="./references#CD010003-bbs2-0137" title="HuisstedeBM , HoogvlietP , RandsdorpMS , GlerumS , Van MiddelkoopM , KoesBW . Carpal tunnel syndrome. Part 1: Effectiveness of nonsurgical treatments - a systematic review. Archives of Physical Medicine and Rehabilitation2010;91(7):981-1004. [PMID: 20599038]">Huisstede 2010</a>). However, the results were inconsistent at long‐term analysis. One study found that overall improvement (remission from nocturnal paraesthesias) was better with corticosteroid injection both at short‐ and long‐term follow‐up. With respect to health‐related quality of life (HRQoL), corticosteroid injections and splint appeared to be comparable (low certainty), but the confidence intervals (CIs) did not exclude benefit for corticosteroid in the short term. Regarding harms, we did not find statistically significant differences in the reporting of adverse effects or in referral to surgery between the two treatments. </p> </section> <section id="CD010003-sec-0184"> <h4 class="title">Comparison of splint wearing regimens</h4> <p>Regarding different splint‐wearing regimens, one study found that six months of splinting may improve symptoms and function (low‐certainty evidence) compared with six weeks splinting, suggesting that the benefits of splinting may manifest late (<a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>). Although the mean difference was at a clinically‐relevant level, the 95% CI overlapped with the MCID value, and it is thus unclear if the effect is clinically relevant. When six weeks of splint use was compared with 12‐week use, there was no evidence of benefit for a longer splinting period in symptoms or function (other outcomes were not measured). </p> </section> </section> <section id="CD010003-sec-0185"> <h3 class="title" id="CD010003-sec-0185">Overall completeness and applicability of evidence</h3> <p>Participants in the studies had a typical age and sex distribution for people with CTS and the results are likely to be applicable to people with mild‐to‐moderate stages of the condition (<a href="./references#CD010003-bbs2-0116" title="AtroshiI , GummessonC , JohnssonR , OrnsteinE , RanstamJ , RosénI . Prevalence of carpal tunnel syndrome in a general population. JAMA1999;282(2):153-8. [PMID: 10411196]">Atroshi 1999</a>; <a href="./references#CD010003-bbs2-0120" title="ConcannonMJ , BrownfieldML , PuckettCL . The incidence of recurrence after endoscopic carpal tunnel release. Plastic and Reconstructive Surgery2000;105(5):1662-5. [PMID: 10809095]">Concannon 2000</a>; <a href="./references#CD010003-bbs2-0138" title="JableckiCK , AndaryMT , FloeterMK , MillerRG , QuartlyCA , VennixMJ , et al, American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation. Practice parameter: electrodiagnostic studies in carpal tunnel syndrome. Report of the American Association of Electrodiagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation. Neurology2002;58(11):1589-92. [PMID: 12058083]">Jablecki 2002</a>; <a href="./references#CD010003-bbs2-0169" title="SzaboRM , SteinbergDR . Nerve entrapment syndromes in the wrist. Journal of the American Academy of Orthopedic Surgeons1994;2(2):115-23.">Szabo 1994</a>). Most studies excluded people with severe CTS and since the effect of splinting seems small at best, biological plausibility does not support the hypothesis that splinting would benefit people with more severe symptoms, established axonal loss and subsequent permanent degenerative changes in the median nerve. However, no studies assessed effects in this population, probably because severe CTS is commonly considered an indication for surgery. </p> <p>Some studies in the splinting versus no active treatment comparison provided education as a co‐intervention (<a href="./references#CD010003-bbs2-0002" title="BoonhongJ , PanyasriwanitS . Neutral wrist splint for mild to moderate carpal tunnel syndrome. Chulalongkorn Medical Journal2017;61(2):151-63. PanyasriwanitS . Combination of wrist splint and conventional treatment vs conventional treatment alone in carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2013;94(10):e63. TCTR20160209001. Three-month neutral wrist splint in mild to moderate carpal tunnel syndrome: a randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160209001 (first received 9 February 2016). ">Boonhong 2017</a>; <a href="./references#CD010003-bbs2-0009" title="HallB , LeeHC , FitzgeraldH , ByrneB , BartonA , LeeAH . Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. American Journal of Occupational Therapy2013;67(4):448-59. ">Hall 2013</a>; <a href="./references#CD010003-bbs2-0026" title="WernerRA , FranzblauA , GellN . Randomized controlled trial of nocturnal splinting for active workers with symptoms of carpal tunnel syndrome. Archives of Physical Medicine and Rehabilitation2005;86(1):1-7. [PMID: 15640980]">Werner 2005</a>), or instruction for home‐based exercises along with splinting and in the control group (<a href="./references#CD010003-bbs2-0008" title="Geler KulcuD , BursaliC , AktasI , Bozkurt AlpS , Unlu OzkanF , AkpinarP . Kinesiotaping as an alternative treatment method for carpal tunnel syndrome. Turkish Journal of Medical Sciences2016;46(4):1042-9. ">Geler Kulcu 2016</a>; <a href="./references#CD010003-bbs2-0015" title="OncuJ , IliserR , Koymen YilmazF , KuranB . Efficacy of kinesiotaping on symptoms, hand functions, and hand grip strength in carpal tunnel syndrome: a single-blind and randomized controlled study. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi2014;60(Suppl 1):S43-51. ">Oncu 2014</a>). Although education may improve coping and could impact the reported values, we deemed that these co‐interventions were unlikely to bias the comparison as they were offered to participants in both groups. Furthermore, we can presume education to be present in normal clinical practice, including in studies that did not report it explicitly. </p> <p>Regarding comparisons of splinting with other active non‐surgical treatment modalities, since splinting has not shown efficacy compared with no splint, these studies provide little guidance whether splinting should be used or not. For this reason we excluded comparisons of specific splint designs. The observed changes in these studies may occur due to nonspecific effects and the between‐group differences can be due to harms of the comparator.  Although we excluded different splint designs from this update, they may be included in future updates if splinting shows clinically relevant efficacy. The major problem with these comparisons is the applicability of the evidence due to specificity of commercial or individually‐tailored splints,  </p> <p>We could not identify an optimal splint‐wearing regimen based on evidence from studies comparing different regimens. There was limited evidence from one study that the benefit may manifest late (<a href="./references#CD010003-bbs2-0018" title="IRCT2013091814704N1. Effectiveness of long term using of splinting in severe CTS. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013091814704N1 (first received 17 May 2015). SanaeeS , RoshanzamirS , HomayouneeK . Efficacy of long-term splinting in the treatment of severe carpal tunnel syndrome. Journal of Musculoskeletal Research2017;20(02):1750013. ">Sanaee 2017</a>), but no studies that compared splinting and no active treatment followed participants for more than six months in the primary analysis and, thus, it is still unclear if splinting can improve symptoms or other outcomes or decrease the need for surgery in long‐term follow‐up. </p> <p>Another potentially important aspect of CTS that the trials did not specifically study was relief of night‐time symptoms. In early CTS, people may suffer night‐time symptoms almost exclusively. None of the studies specifically measured night‐time symptom relief. Night‐time symptoms comprise only 4/11 (36% weight) items in the BCTQ symptom severity score and patient‐important benefits (e.g. better sleep and consequent improved daytime quality of life) may not be evident when BCTQ is used as the outcome measure for 'symptoms'. </p> <p>We used CTS symptoms (a continuous outcome) as the primary outcome because very few studies measured global improvement (which was used in the previous update of this review as the primary outcome; <a href="./references#CD010003-bbs2-0176" title="PageMJ , Massy-WestroppN , O'ConnorD , PittV . Splinting for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2012, Issue 7. Art. No: CD010003. [DOI: 10.1002/14651858.CD010003]">Page 2012b</a>) and we could not identify evidence suggesting that global improvement would be a clinically more relevant outcome. We excluded neurophysiological outcomes. Although they may be considered objective measures of improvement, their clinical relevance is unclear; if the possible benefit in conduction velocity does not translate to an improvement in symptoms, function, or health‐related quality of life, it is not likely to be meaningful to people with CTS. </p> <p>We did not include comparisons to surgery, as they are covered in another review (<a href="./references#CD010003-bbs2-0171" title="VerdugoRJ , SalinasRS , CastilloJ , CeaJG . Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD001552. [DOI: 10.1002/14651858.CD001552.pub2]">Verdugo 2008</a>). We also excluded studies that compared splinting with a non‐surgical intervention aimed at symptom modification. These interventions include electroacupuncture; yoga; gabapentin; flax seed oil; interferential current; or phonophoresis. </p> </section> <section id="CD010003-sec-0186"> <h3 class="title" id="CD010003-sec-0186">Quality of the evidence</h3> <p>None of the included studies was at low risk of bias. The main study limitation was lack of blinding (high risk of performance and detection bias). We identified one ongoing study using soft bandage as a placebo control (<a href="./references#CD010003-bbs2-0108" title="AtroshiI , TadjerbashiK , McCabeSJ , RanstamJ . Treatment of carpal tunnel syndrome with wrist splinting: study protocol for a randomized placebo-controlled trial. Trials2019;20(1):531. [DOI: https://doi.org/10.1186/s13063-019-3635-6]ISRCTN81836603. Evaluation of wrist splinting for the treatment of carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN81836603 (first received 2 May 2018). ">Atroshi 2019</a>). Presumably soft bandage does not exert an effect, but nevertheless the participants were not blinded, and participant preconceptions can modify perceived improvement. It may not be feasible to create a placebo splint that achieves adequate blinding and does not exert any effect. Although meta‐epidemiological studies indicate that a lack of blinding of participants or study personnel can affect estimates of effect (<a href="./references#CD010003-bbs2-0163" title="SavovicJ , TurnerRM , MawdsleyD , JonesHE , BeynonR , HigginsJP , et al. Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study. American Journal of Epidemiology2018;187(5):1113-22.">Savovic 2018</a>), recent evidence suggests that this effect may be small (<a href="./references#CD010003-bbs2-0145" title="MoustgaardH , ClaytonGL , JonesHE , BoutronI , JørgensenL , LaursenDRT , et al. Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study. BMJ2020;368:l6802.">Moustgaard 2020</a>). As bias from lack of blinding is likely to be context‐dependent, it is unclear how much it can bias the estimates. We hypothesise that if splinting does not show a relevant effect in non‐blinded trials, we should assume that blinded trials will find an even smaller effect.  </p> <p>We downgraded the evidence in the primary outcome for splint compared to no active treatment due to inconsistency. While two studies with high or unclear risk of selection bias reported statistically significant benefits for splinting, the studies at low risk of selection bias found a virtually null effect. </p> <p>For function, the evidence was moderate (downgraded for risk of bias), the estimates excluding the MCID value. For overall improvement, we downgraded the certainty of evidence to low due to risk of bias and imprecision, as there was only one small study with 80 participants. Regarding harms, we downgraded the certainty of evidence for risk of bias (lack of blinding) and imprecision (the 95% CI included no effect). </p> <p>Most secondary comparisons included one small unblinded study. Therefore, the estimates were often imprecise (moderate to low certainty of evidence, depending on the comparison and outcome). </p> <p>Heterogeneity in the reported MCID values adds another layer of uncertainty to interpretation of the results. We used a MCID of 1 point (on a 1 to 5 scale) for BCTQ symptom severity score and 0.7 for BCTQ functional status score (<a href="./references#CD010003-bbs2-0141" title="KimJK , JeonSH . Minimal clinically important differences in the Carpal Tunnel Questionnaire after carpal tunnel release. Journal of Hand Surgery. European Volume2013;38(1):75-9.">Kim 2013</a>), both from the mid‐range of reported values (<a href="./references#CD010003-bbs2-0123" title="De KleermaekerFG , BoogaartsHD , MeulsteeJ , VerhagenWI . Minimal clinically important difference for the Boston Carpal Tunnel Questionnaire: new insights and review of literature. Journal of Hand Surgery, European Volume2018;44(3):283-9.">De Kleermaeker 2018</a>). MCID values have often been defined in surgical studies, and may not apply directly to splinting. A MCID of 1 point is a relatively high value when translated to a standardised mean difference (SMD) (corresponds with large effect; SMD of 1.25 to 2). Although the chosen MCID value did not affect the estimates, a better understanding of what constitutes a meaningful change in people who use a splint would affect interpretation of results. For example, if we assume a MCID in the symptom scale that is 10% of the scale (0.4 points; corresponding with a medium to large effect, SMD of 0.6 to 1), our conclusions would be that splinting may provide clinically important benefits in carpal tunnel symptoms. However, inconsistency, imprecision and bias would still decrease our certainty, and more rigorous studies are needed. </p> <p>Conflicts of interest were rarely reported: only two studies reported conflicts of interest that could affect the findings: one due to a patent on the splint used in the trial (<a href="./references#CD010003-bbs2-0013" title="ManenteG , TorrieriF , Di BlasioF , StanisciaT , RomanoF , UnciniA . An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle &amp; Nerve2001;24(8):1020-5. [PMID: 11439376]">Manente 2001</a>), and the other because two authors had been employed by the manufacturer of the tested stretching splint (<a href="./references#CD010003-bbs2-0027" title="NCT00558116. Treatment of carpal tunnel syndrome with dynamic splinting. clinicaltrials.gov/show/NCT00558116 (first received 14 Nov 2007). WillisFB , FowlerB . Longitudinal outcomes following a randomized controlled trial of dynamic splint stretching for carpal tunnel syndrome. Hand2016;11(3):290-4. ">Willis 2016</a>). </p> </section> <section id="CD010003-sec-0187"> <h3 class="title" id="CD010003-sec-0187">Potential biases in the review process</h3> <p>We conducted searches according to Cochrane methodological standards and did not restrict searches by language or date. It is unlikely that we missed large‐scale rigorous trials. However, based on clinical trial registries, we identified six potentially eligible studies that lacked the needed information or were not published, which are awaiting classification (<a href="./references#CD010003-bbs2-0102" title="BaklaciK . Long-term effectiveness of physical therapy modalities in carpal tunnel syndrome. Internal Medicine Journal2015;45(Suppl 2):12. ">Baklaci 2015</a>; <a href="./references#CD010003-bbs2-0103" title="BhuvaVD , JagtapV . Effect of customized splint and soft tissue mobilization exercises in carpal tunnel syndrome. Indian Journal of Physiotherapy &amp; Occupational Therapy2019;13(3):121-6. ">Bhuva 2019</a>; <a href="./references#CD010003-bbs2-0104" title="IRCT2014020416485N1. Therapeutic effect of ultrasound-guided local steroid injection with hydro-dissection in carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014020416485N1 (first received 4 May 2014). ">IRCT2014020416485N1</a>; <a href="./references#CD010003-bbs2-0105" title="ISRCTN22916517. Comparison of wrist splints and steroid injection for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN22916517 (first received 12 September 2003). ">ISRCTN22916517</a>; <a href="./references#CD010003-bbs2-0106" title="RiasiH , Rajabpour SanatiA , SalehiF , SalehianH , GhaemiK . Analyzing the therapeutic effects of short wrist splint in patients with carpal tunnel syndrome (CTS) under ibuprofen treatment from an EMG-NCV perspective. Journal of Medicine and Life 2015;8(Special Issue 4):154-8. ">Riasi 2015</a>; <a href="./references#CD010003-bbs2-0107" title="ACTRN12613000140752. A randomised clinical trial of physiotherapy, therapeutic ultrasound and hand splinting for carpal tunnel syndrome. who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12613000140752 (first received 6 February 2013). SoonB , VicenzinoB , PlumbeL , CoppietersM . Randomised clinical trial on efficacy of combining hand splinting with physiotherapy or ultrasound treatment for patients with carpal tunnel syndrome. Physiotherapy (United Kingdom)2015;101:eS1422-eS3. ">Soon 2015</a>). Inclusion of these trials could affect the estimates in this review.  </p> <p>Another study was included, but the authors did not report sufficient data to contribute to the analyses (<a href="./references#CD010003-bbs2-0017" title="Rioja ToroJ , Estévez PoyPJ , Martínez PardoF . A prospective, randomized and placebo controlled study of the efficacy of treatment with laser, with or without splinting of wrist in idiopathic carpal tunnel syndrome. Rehabilitacion2012;46(2):92-102. ">Rioja Toro 2012</a>).  </p> </section> <section id="CD010003-sec-0188"> <h3 class="title" id="CD010003-sec-0188">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review are generally consistent with those of other systematic reviews of non‐surgical interventions for CTS, which conclude that splinting may be more effective than no treatment, but is not more or less effective than other non‐surgical interventions (<a href="./references#CD010003-bbs2-0115" title="AshworthN . Carpal tunnel syndrome. Clinical Evidence2010;2010:1114. [PMID: 21718565]">Ashworth 2010</a>; <a href="./references#CD010003-bbs2-0129" title="GerritsenAA , De KromMC , StruijsMA , ScholtenRJ , De VetHC , BouterLM . Conservative treatment options for carpal tunnel syndrome: a systematic review of randomised controlled trials. Journal of Neurology2002;249(3):272-80. [PMID: 11993525]">Gerritsen 2002b</a>; <a href="./references#CD010003-bbs2-0130" title="Goodyear-SmithF , ArrollB . What can family physicians offer patients with carpal tunnel syndrome other than surgery? A systematic review of nonsurgical management. Annals of Family Medicine2004;2(3):267-73. [PMID: 15209206]">Goodyear‐Smith 2004</a>; <a href="./references#CD010003-bbs2-0137" title="HuisstedeBM , HoogvlietP , RandsdorpMS , GlerumS , Van MiddelkoopM , KoesBW . Carpal tunnel syndrome. Part 1: Effectiveness of nonsurgical treatments - a systematic review. Archives of Physical Medicine and Rehabilitation2010;91(7):981-1004. [PMID: 20599038]">Huisstede 2010</a>; <a href="./references#CD010003-bbs2-0146" title="MullerM , TsuiD , SchnurrR , Biddulph-Deisroth, HardJ , MacDermidJ . Effectiveness of hand therapy interventions in primary management of carpal tunnel syndrome: a systematic review. Journal of Hand Therapy2004;17(2):210-28. [PMID: 15162107]">Muller 2004</a>; <a href="./references#CD010003-bbs2-0149" title="OnoS , ClaphamPJ , ChungKC . Optimal management of carpal tunnel syndrome. International Journal of General Medicine2010;3:255-61. [PMID: 20830201]">Ono 2010</a>; <a href="./references#CD010003-bbs2-0158" title="PiazziniDB , AprileI , FerraraPE , BertoliniC , TonaliP , MaggiL , et al. A systematic review of conservative treatment of carpal tunnel syndrome. Clinical Rehabilitation2007;21(4):299-314.">Piazzini 2007</a>).  </p> <p>Compared to the previous version of this review, we included 20 new studies, and we could pool more data in comparisons of splint versus no active intervention and splint versus corticosteroid. The findings largely agree with the previous version of the review regarding uncertainty of benefits, but we improved certainty regarding symptoms and function in the main analysis (increasing the certainty of evidence from very low to low certainty). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010003-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-FIG-01" target="_blank"><b></b></a></p> </div><img alt="1 ‐ reasons for exclusion: in 5 studies the effect of splinting cannot be isolated from that of the other intervention delivered alongside it; in 29 studies splint applied to each study group; 7 studies compare treatment methods which we defined as not relevant for this review; 5 studies were not a randomised trial" data-id="CD010003-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>1 ‐ reasons for exclusion: in 5 studies the effect of splinting cannot be isolated from that of the other intervention delivered alongside it; in 29 studies splint applied to each study group; 7 studies compare treatment methods which we defined as not relevant for this review; 5 studies were not a randomised trial </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD010003-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 1: CTS symptoms (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 3: Overall improvement" data-id="CD010003-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 3: Overall improvement</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 4: Adverse effects" data-id="CD010003-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 4: Adverse effects</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 5: Referral for surgery" data-id="CD010003-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: SPLINT VERSUS NO ACTIVE TREATMENT, Outcome 5: Referral for surgery</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 1: CTS symptoms" data-id="CD010003-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 1: CTS symptoms</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 3: Overall improvement" data-id="CD010003-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 3: Overall improvement</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 4: Health‐related quality of life" data-id="CD010003-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 4: Health‐related quality of life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 5: Adverse effects" data-id="CD010003-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 5: Adverse effects</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 6: Referral for surgery" data-id="CD010003-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: SPLINT VERSUS CORTICOSTEROID INJECTION, Outcome 6: Referral for surgery</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SPLINT VERSUS ORAL STEROID, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: SPLINT VERSUS ORAL STEROID, Outcome 1: CTS symptoms (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SPLINT VERSUS ORAL STEROID, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: SPLINT VERSUS ORAL STEROID, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SPLINT VERSUS ORAL STEROID, Outcome 3: Adverse effects" data-id="CD010003-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: SPLINT VERSUS ORAL STEROID, Outcome 3: Adverse effects</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION, Outcome 1: CTS symptoms (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION, Outcome 2: Function (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION, Outcome 3: Overall improvement" data-id="CD010003-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION, Outcome 3: Overall improvement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: SPLINT VERSUS EXERCISE, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: SPLINT VERSUS EXERCISE, Outcome 1: CTS symptoms (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: SPLINT VERSUS EXERCISE, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: SPLINT VERSUS EXERCISE, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: STRETCHING SPLINT VERSUS STRETCHING EXERCISES, Outcome 1: Referral for surgery" data-id="CD010003-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: STRETCHING SPLINT VERSUS STRETCHING EXERCISES, Outcome 1: Referral for surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: SPLINT VERSUS KINESIOLOGY TAPING, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: SPLINT VERSUS KINESIOLOGY TAPING, Outcome 1: CTS symptoms (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: SPLINT VERSUS KINESIOLOGY TAPING, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: SPLINT VERSUS KINESIOLOGY TAPING, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: SPLINT VERSUS RIGID TAPE, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: SPLINT VERSUS RIGID TAPE, Outcome 1: CTS symptoms (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: SPLINT VERSUS RIGID TAPE, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: SPLINT VERSUS RIGID TAPE, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: SPLINT VERSUS PLATELET RICH PLASMA (PRP), Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: SPLINT VERSUS PLATELET RICH PLASMA (PRP), Outcome 1: CTS symptoms (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: SPLINT VERSUS PLATELET RICH PLASMA (PRP), Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: SPLINT VERSUS PLATELET RICH PLASMA (PRP), Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: SPLINT VERSUS EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT), Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: SPLINT VERSUS EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT), Outcome 1: CTS symptoms (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: SPLINT VERSUS EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT), Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: SPLINT VERSUS EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT), Outcome 2: Function (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: DYNAMIC SPLINT PLUS REHABILITATION VERSUS REHABILITATION, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: DYNAMIC SPLINT PLUS REHABILITATION VERSUS REHABILITATION, Outcome 1: CTS symptoms (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-011.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: DYNAMIC SPLINT PLUS REHABILITATION VERSUS REHABILITATION, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-011.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-011.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11: DYNAMIC SPLINT PLUS REHABILITATION VERSUS REHABILITATION, Outcome 2: Function (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-011.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS, Outcome 1: CTS symptoms (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-012.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-012.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-012.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12: SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-012.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-012.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS, Outcome 3: Referral for surgery" data-id="CD010003-fig-0035" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-012.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-012.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12: SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS, Outcome 3: Referral for surgery</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-012.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-013.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0036" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-013.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-013.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13: SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS, Outcome 1: CTS symptoms (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-013.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-013.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0037" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-013.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-013.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13: SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS, Outcome 2: Function (BCTQ)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-013.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-013.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS, Outcome 3: Referral for surgery" data-id="CD010003-fig-0038" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-013.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-013.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13: SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS, Outcome 3: Referral for surgery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-013.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-014.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: NIGHT‐TIME SPLINTING VERSUS FULL‐TIME SPLINTING, Outcome 1: CTS symptoms (BCTQ)" data-id="CD010003-fig-0039" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-014.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-014.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14: NIGHT‐TIME SPLINTING VERSUS FULL‐TIME SPLINTING, Outcome 1: CTS symptoms (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-014.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010003-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/urn:x-wiley:14651858:media:CD010003:CD010003-CMP-014.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: NIGHT‐TIME SPLINTING VERSUS FULL‐TIME SPLINTING, Outcome 2: Function (BCTQ)" data-id="CD010003-fig-0040" src="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-014.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_t/tCD010003-CMP-014.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14: NIGHT‐TIME SPLINTING VERSUS FULL‐TIME SPLINTING, Outcome 2: Function (BCTQ) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/media/CDSR/CD010003/image_n/nCD010003-CMP-014.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010003-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b> SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> carpal tunnel syndrome<br/><b>Setting: </b> outpatient clinics in Italy, Thailand and Turkey; hospital clinic in Australia; education and research hospital in Turkey; auto assembly plant in the USA<br/><b>Intervention:</b> SPLINT<br/><b>Comparison:</b> NO ACTIVE TREATMENT </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NO ACTIVE TREATMENT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with SPLINT</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CTS symptoms (Boston CTS questionnaire) ‐ short‐term improvement: &lt; 3 months<br/>Scale: 1 to 5, higher is worse </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean CTS symptoms severity was <b>2.37 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.37 points better</b><br/>(0.82 better to 0.08 worse) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Splint may not improve CTS symptoms in the short term. Absolute difference 9.25% better (20.5% better to 2% worse) with splint<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CTS symptoms (Boston CTS questionnaire) ‐ long‐term improvement: &gt; 3 months<br/>Scale: 1 to 5, higher is worse </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean CTS symptoms severity was <b>2.48 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.64 points better</b><br/>(1.2 better to 0.08 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain if splint improves CTS symptoms in the long term. Absolute difference 16% better (30% better to 2% better) with splint </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Function (Boston CTS questionnaire) ‐ long‐term improvement: &gt; 3 months<br/>Scale: 1 to 5, higher is worse </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean function was <b>1.77 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.25 points better</b><br/>(0.68 better to 0.18 worse) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Splint may not improve hand function in the long term. Absolute difference 6.25% better (17% better to 4.5% worse) with splint </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Overall improvement (improved/not improved or worsened) ‐ short‐term improvement: &lt; 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.86<br/>(2.29 to 6.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>More people may report overall improvement in the short term with a splint than without a splint. Absolute risk difference 75% better (61% better to 89% better ) with splint. NNTB 2 (95% CI 2 to 2) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>965 per 1000</b><br/>(573 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life ‐ long‐term improvement: &gt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable. We are uncertain about the effect.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effects</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 15.00<br/>(0.89 to 254.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Splint may increase risk of transient adverse effects. Absolute risk difference 17% worse (5% worse to 30% worse) with splint </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not calculable from the study data. 0/40 (0%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not calculable from the study data. 7/40 (18%)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Referral for surgery</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.47<br/>(0.14 to 1.58) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>243<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain if splint can reduce referral for surgery. Absolute risk difference 4% better (11% better  to 3% worse) with splint </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b><br/>(11 to 125) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio; <b>CTS</b>: carpal tunnel syndrome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for high risk of bias in the included studies (lack of blinding)<br/><sup>b</sup>Downgraded one level for inconsistency (the estimates were not consistent between the studies)<br/><sup>c</sup>Absolute risk difference calculated as risk in control group ‐ risk in the splinting group<br/><sup>d</sup>Downgraded for imprecision (the 95% did not exclude clinically relevant effects)<br/><sup>e</sup>Downgraded twice for very serious imprecision (95% CIs included substantial effect in both directions)<br/>  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010003-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome ‐ outcomes that are not presented in the summary of findings table</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome ‐ outcomes that are not presented in the summary of findings table</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> carpal tunnel syndrome<br/><b>Setting: </b> outpatient clinics in Italy, Thailand and Turkey; hospital clinic in Australia; education and research hospital in Turkey<br/><b>Intervention:</b> SPLINT<br/><b>Comparison:</b> NO ACTIVE TREATMENT </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect</b> <br/><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NO ACTIVE TREATMENT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with SPLINT</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional status (Boston CTS questionnaire) ‐ short‐term improvement: &lt; 3 months. Scale: 1 to 5, higher is worse </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean function was <b>1.97</b> points </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.24 points better</b><br/>(0.44 better to 0.03 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Splint probably does not improve hand function in the short term. Absolute difference 6% better (11% better to 0.75% better) with splint </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall improvement ‐ long‐term improvement: &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable. We are uncertain about the effect.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life ‐ short‐term improvement: &lt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable. We are uncertain about the effect.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD</b> : mean difference; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio; <b>CTS</b>: carpal tunnel syndrome </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for high risk of bias in the included studies (lack of blinding) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">SPLINT compared to NO ACTIVE TREATMENT for carpal tunnel syndrome ‐ outcomes that are not presented in the summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/full#CD010003-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SPLINT VERSUS NO ACTIVE TREATMENT</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.82, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Long‐term improvement: &gt; 3months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐1.20, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.44, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Long‐term improvement: &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.68, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Overall improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [2.29, 6.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.00 [0.89, 254.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Referral for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.14, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SPLINT VERSUS NO ACTIVE TREATMENT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SPLINT VERSUS CORTICOSTEROID INJECTION</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 CTS symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Long‐term improvement: over 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.66, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.04, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Long‐term improvement: over 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [‐0.40, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Overall improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.39, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Long‐term improvement: over 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.22, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Health‐related quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.77, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Long‐term improvement: over 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.21, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.08, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Referral for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.33, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SPLINT VERSUS CORTICOSTEROID INJECTION</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SPLINT VERSUS ORAL STEROID</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.03, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.06, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.86 [0.24, 97.86]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SPLINT VERSUS ORAL STEROID</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.43, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.28, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Overall improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.90, 1.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SPLINT PLUS CORTICOSTEROID INJECTION VERSUS CORTICOSTEROID INJECTION</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SPLINT VERSUS EXERCISE</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.38, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.11, 0.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SPLINT VERSUS EXERCISE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">STRETCHING SPLINT VERSUS STRETCHING EXERCISES</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Referral for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.22, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">STRETCHING SPLINT VERSUS STRETCHING EXERCISES</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SPLINT VERSUS KINESIOLOGY TAPING</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [‐0.05, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.54, 0.75]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SPLINT VERSUS KINESIOLOGY TAPING</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SPLINT VERSUS RIGID TAPE</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.58, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.48, 1.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SPLINT VERSUS RIGID TAPE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SPLINT VERSUS PLATELET RICH PLASMA (PRP)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.2 Long‐term improvement: &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.16, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.2 Long‐term improvement: &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.12, 0.52]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SPLINT VERSUS PLATELET RICH PLASMA (PRP)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">SPLINT VERSUS EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.40, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.44, 0.24]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">SPLINT VERSUS EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">DYNAMIC SPLINT PLUS REHABILITATION VERSUS REHABILITATION</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.61, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.67, 0.51]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">DYNAMIC SPLINT PLUS REHABILITATION VERSUS REHABILITATION</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.62, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.39, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.3 Referral for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3.1 Long‐term improvement: over 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.12, 2.83]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">SPLINT SIX WEEKS VERSUS SPLINT 12 WEEKS</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.1 Long‐term improvement: &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.81, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.1 Long‐term improvement: &gt; 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [1.44, 3.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.3 Referral for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.00 [0.50, 163.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">SPLINT SIX WEEKS VERSUS SPLINT SIX MONTHS</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010003-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">NIGHT‐TIME SPLINTING VERSUS FULL‐TIME SPLINTING</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.1 CTS symptoms (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1.1 Short‐term improvement: 3 months or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.83, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.2 Function (BCTQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2.1 At the end of 6 weeks treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.87, 0.45]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">NIGHT‐TIME SPLINTING VERSUS FULL‐TIME SPLINTING</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010003.pub2/references#CD010003-tbl-0016">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010003.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010003-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010003-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010003-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010003-note-0010">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010003-note-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="hu#CD010003-note-0011">Magyar</a> </li> <li class="section-language"> <a class="" href="ja#CD010003-note-0016">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD010003-note-0007">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010003-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010003-note-0018">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD010003-note-0015">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010003-note-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010003-note-0014">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010003\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010003\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010003\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010003\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010003.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010003.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010003.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010003.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010003.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716223244"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010003.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716223247"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010003.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9a3f0e951bf6',t:'MTc0MDcxNjIyMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 